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	22	
Abstract	(150/150	words)		23	 The	temporal	regulation	of	protein	abundance	and	post-translational	modifications	is	a	24	 key	feature	of	cell	division.	Recently,	we	analysed	gene	expression	and	protein	25	 abundance	changes	during	interphase	under	minimally	perturbed	conditions	(Ly	et	al.	26	 2014;	Ly	et	al.	2015).	Here	we	show	that	by	using	specific	intracellular	immunolabeling	27	 protocols,	FACS	separation	of	interphase	and	mitotic	cells,	including	mitotic	subphases,	28	 can	be	combined	with	proteomic	analysis	by	mass	spectrometry.	Using	this	PRIMMUS	29	 (PRoteomic	analysis	of	Intracellular	iMMUnolabeled	cell	Subsets)	approach,	we	now	30	 compare	protein	abundance	and	phosphorylation	changes	in	interphase	and	mitotic	31	 fractions	from	asynchronously	growing	human	cells.	We	identify	a	set	of	115	32	 phosphorylation	sites	increased	during	G2,	termed	‘early	risers’.	This	set	includes	33	 phosphorylation	of	S738	on	TPX2,	which	we	show	is	important	for	TPX2	function	and	34	 mitotic	progression.	Further,	we	use	PRIMMUS	to	provide	the	first	a	proteome-wide	35	 analysis	of	protein	abundance	remodeling	between	prophase,	prometaphase	and	36	 anaphase.		37	
	 	38	
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Introduction	39	
	40	 The	mitotic	cell	division	cycle	is	composed	of	four	major	phases,	i.e.,	G1,	S,	G2	41	 and	M.	The	phases	are	defined	by	two	major	events	during	cell	division:	DNA	replication	42	 (S	phase)	and	mitosis	(M	phase),	with	intervening	gap	phases	(G1	and	G2).	The	cell	43	 cycle	is	driven	by	the	expression	of	key	proteins,	called	cyclins.	Generally,	cyclin	44	 expression	and	function	is	restricted	to	specific	cell	cycle	phases,	driving	temporally	45	 ordered	phosphorylation	of	key	substrates	by	interacting	with	their	kinase	partners,	the	46	 cyclin	dependent	kinases	(CDKs).	Temporally	regulated	degradation	of	the	cyclins	47	 ensures	that	progression	through	the	cell	cycle	is	unidirectional.	For	example,	cyclin	A	48	 expression	increases	during	S-phase,	reaching	a	maximum	in	mitosis.	During	49	 prometaphase,	cyclin	A	is	targeted	for	degradation	by	the	anaphase	promoting	50	 complex/cyclosome	(APC/C),	a	multiprotein	E3	ubiquitin	ligase,	thus	restricting	cyclin	51	 A-driven	phosphorylation	to	S,	G2	and	early	M-phase.		52	 Mitosis	can	be	further	resolved	into	subphases	(i.e.	prophase,	prometaphase,	53	 metaphase,	anaphase,	telophase	&	cytokinesis),	which	are	characterised	by	the	54	 widespread	reorganization	of	subcellular	architecture.	For	example,	in	prophase,	55	 duplicated	centrosomes	separate	to	form	the	poles	of	the	mitotic	spindle.	Centrosome	56	 separation	is	dependent	on	the	activities	of	several	kinases,	including	Cdk1	and	Plk1	57	 (Smith	et	al.	2011),	and	on	the	microtubule	motor	protein	Eg5	(Sawin	et	al.	1992).	58	 Improperly	timed	centrosome	separation	can	lead	to	chromosomal	instability,	as	shown	59	 in	cyclin	B2-overexpressing	MEFs	(Nam	&	van	Deursen	2014).	From	prophase	to	60	 prometaphase,	nuclear	envelope	breakdown	occurs	and	spindle	assembly	begins.	61	 During	prometaphase,	proper	kinetochore	microtubule	attachments	form,	which	62	 depend	on	the	interaction	of	each	kinetochore	on	the	sister	chromatids	forming	stable,	63	 end	on	attachments	to	spindle	microtubules.		The	recruitment	of	Eg5	to	spindle	64	
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microtubules	is	promoted	by	the	microtubule-nucleating	protein	TPX2	(Eckerdt	et	al.	65	 n.d.;	Ma	et	al.	2010;	Ma	et	al.	2011).	Expression	of	a	TPX2	mutant	lacking	the	Eg5-66	 interaction	domain	leads	to	defects	in	spindle	assembly	and	mitotic	arrest	(Ma	et	al.	67	 2011).		68	 Scheduled	degradation	of	proteins	is	crucial	for	linking	chromosome	alignment	69	 and	segregation	(King	et	al.	1996)	and	is	therefore	an	important	regulatory	mechanism	70	 for	maintaining	genome	stability	during	cell	division.	Indeed,	disruption	of	the	71	 scheduled	degradation	of	key	proteins,	such	as	cyclins	A	and	B,	can	lead	to	nuclear	72	 abnormalities,	hyperplasia	(Bortner	&	Rosenberg	1995)	and	chromosomal	instability	73	 (Nam	&	van	Deursen	2014).			74	 	 A	major	challenge	with	the	biochemical	analysis	of	mitosis	is	that	mitotic	75	 subphase	durations	are	on	the	minute	timescale	(Sullivan	&	Morgan	2007),	with	cell-to-76	 cell	variability	in	dwell	times.	This	has	hampered	attempts	to	perform	a	comprehensive	77	 analysis	of	protein	abundance	changes	during	mitotic	progression	due	to	the	difficulty	78	 in	obtaining	highly	synchronous	cell	populations	in	the	various	intra-mitotic	stages	in	79	 sufficient	numbers	for	proteome	analysis.	Additionally,	emerging	evidence	suggests	that	80	 methods	used	to	either	synchronise,	or	arrest	cells	in	mitosis,	may	induce	artefacts	that	81	 are	not	observed	during	an	unperturbed	cell	cycle	(Ly	et	al.	2015).	It	has	also	been	82	 shown	that	long-term	spindle	assembly	checkpoint	(SAC)	activation	can	lead	to	what	is	83	 termed	either	mitotic	‘exhaustion’,	or	‘collapse’,	due	to	sustained	degradation	in	the	84	 presence	of	an	active	checkpoint	(Balachandran	et	al.	2016).	85	 Technological	advances	in	mass	spectrometry	(MS)-based	proteomics	have	86	 enabled	the	large-scale	detection	and	quantitation	of	proteins,	including	measurement	87	 of	properties	such	as	absolute	abundances	and	subcellular	localization	(Larance	&	88	 Lamond	2015).	However,	proteome	measurements	on	either	cultured	cells,	or	tissues,	89	
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reflect	average	values	across	a	cell	population	and	detailed	information	on	biochemical	90	 state	heterogeneity	is	obscured.	A	powerful	approach	for	separating	cellular	91	 subpopulations	involves	immunostaining	combined	with	Fluorescence	Activated	Cell	92	 Sorting	(FACS).	CyTOF	is	one	example	combining	the	single	cell	separation	power	of	93	 flow	cytometry	with	accurate	mass	measurement	and	quantitation	by	mass	94	 spectrometry	(Bendall	et	al.	2011).	In	CyTOF,	immunological	reagents	are	conjugated	95	 with	heavy	metal	isotopes.	Cellular	material	is	then	atomized	for	mass	analysis	of	96	 individual	atoms,	which	report	on	the	abundance	of	the	immunological	reagent	binding	97	 to	cells.	We	note	that	CyTOF,	while	significantly	increasing	the	number	of	protein	98	 antigens	detected	as	compared	with	a	fluorescence-based	assay,	currently	does	not	99	 achieve	the	same	high	depth	of	proteome	coverage,	extending	to	thousands	of	proteins,	100	 that	can	now	be	obtained	by	large-scale,	MS-based	proteomic	methods	(Hukelmann	et	101	 al.	2016;	Bekker-Jensen	et	al.	2017;	Tyanova	et	al.	2016;	Wilhelm	et	al.	n.d.).	102	 Furthermore,	apart	from	lower	proteome	coverage,	CyTOF	also	has	more	limited	ability	103	 to	identify	post-translational	protein	modifications	and	is	a	target-focused	approach,	in	104	 contrast	with	the	unbiased	analysis	provided	by	MS-based	proteomics.	105	 Until	now,	studies	combining	FACS	and	MS-based	proteomics	have	mostly	106	 involved	isolating	cell	subpopulations	based	on	labeling	of	cell	surface	antigens,	hence	107	 avoiding	cell	permeabilisation	and	fixation	(Di	Palma	et	al.	2011),(Bonardi	et	al.	2013).	108	 Problems	with	sample	bias	and	protein	losses	have	been	encountered	in	studies	using	109	 MS-based	proteomic	methods	when	cells	are	permeabilised	and	fixed	(Toews	et	al.	110	 2008),	as	required	for	immunodetection	of	intracellular	antigens.	Indeed,	to	avoid	111	 intracellular	immunostaining,	recent	work	sought	to	identify	mitosis-specific	cell	112	 surface	markers	that	can	be	used	with	live	cells	to	isolate	mitotic	cell	subpopulations	in	113	 HeLa	cells	(Ozlu	et	al.	2015).	However,	as	far	as	we	are	aware,	neither	fluorescence	114	
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abundance	reporter	systems,	nor	cell	surface	markers,	have	been	reported	to	115	 distinguish	effectively	between	mitotic	subphases,	e.g.	prophase,	prometaphase,	116	 metaphase	&	anaphase,	suitable	for	discrimination	and	purification	by	FACS.	117	 Previously,	we	reported	a	comprehensive	proteomic	dataset	measuring	protein	118	 and	mRNA	abundance	variation	across	interphase	(G1,	S,	and	G2&M)	of	the	cell	cycle	119	 (Ly	et	al.	2014).	To	prepare	cell	cycle	enriched	cell	populations,	we	used	centrifugal	120	 elutriation	(Banfalvi	2011),	a	method	that	minimizes	physiological	perturbation	to	cells	121	 and	thus	avoids	indirect	effects	modulating	gene	expression	associated	with	arrest	122	 procedures	(Ly	et	al.	2015).	While	elutriation	was	effective	for	isolating	interphase	123	 subpopulations	from	human	leukemia	cells	for	proteome	analysis,	there	were	124	 limitations	in	resolution.	In	particular,	mitotic	cells	are	poorly	enriched	relative	to	G2	125	 cells.	In	contrast,	G2	and	mitotic	cells	can	be	efficiently	distinguished	using	intracellular	126	 immunostaining	and	flow	cytometry	(Jacobberger	et	al.	2008;	Pozarowski	&	127	 Darzynkiewicz	2004).	128	 Building	on	our	previous	work	analysing	the	cell	cycle	regulated	interphase	129	 proteome	(Ly	et	al.	2014;	Ly	et	al.	2015),	we	present	here	a	workflow	for	performing	130	
proteomics	of	intracellular	immunolabeled	subpopulations	of	cells	(PRIMMUS).	Using	131	 PRIMMUS,	we	perform	a	proteome-wide	analysis	of	changes	in	protein	abundance	and	132	 phosphorylation	during	interphase.	Further,	we	perform	the	first	proteomic	133	 characterization	of	distinct	mitotic	substages,	with	high	enrichment	efficiencies	134	 between	prophase,	prometaphase	and	anaphase	in	human	NB4	cells.	All	of	these	135	 proteomic	data	are	freely	available,	both	as	raw	MS	files	via	the	ProteomeXchange	136	 PRIDE	repository	(http://www.ebi.ac.uk/pride,	PXD007787)	and	as	quantified	protein-137	 level	data,	via	the	Encyclopedia	of	Proteome	Dynamics	(www.peptracker.com/EPD),	a	138	 searchable,	online	database	(Larance	et	al.	2013;	Brenes	et	al.	2017).	139	
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Results	140	
Optimization	of	cell	fixation	&	permeabilisation	for	proteome	analysis	141	 We	identified	three	steps	in	intracellular	immunostaining	procedures	that	have	142	 the	potential	to	significantly	impact	peptide	identification	by	MS-based	proteomics:	(1)	143	 irreversibility	and/or	chemical	modifications	associated	with	cell	fixation,	(2)	loss	of	144	 soluble	proteins	during	permeabalisation	and	(3)	interference	from	antibody-derived	145	 peptides	(Fig.	1A).	Therefore,	a	series	of	experiments	were	performed	to	compare	146	 alternative	fixation	and	permeabilisation	parameters	with	respect	to	these	effects.		147	 We	chose	to	fix	cells	with	formaldehyde	(FA),	which	has	been	used	extensively	148	 for	other	MS	applications,	such	as	protein-protein	crosslinking	(Larance	et	al.	2016)	and	149	 crosslinked	immunoprecipitations	(Mohammed	et	al.	2016;	Klockenbusch	&	Kast	2010).	150	 FA	forms	reversible	crosslinks	that	can	be	broken	efficiently	at	high	temperatures.	151	 However,	prior	work	on	model	peptides	shows	that	high	FA	concentrations	can	produce	152	 irreversible	chemical	modifications	that	compromise	identification	by	MS	(Toews	et	al.	153	 2008),(Sutherland	et	al.	2008).	FA	concentrations	and	fixation	times	vary	significantly	154	 between	common	immunostaining	protocols	(Stadler	et	al.	2010;	Stadler	et	al.	2013).	155	 Therefore,	we	tested	a	range	of	FA	concentrations	in	human	myeloid	leukemia	NB4	156	 cells,	employing	SDS-PAGE,	immunoblotting	and	total	protein	gel	stains	to	assay	for	157	 crosslinking	efficiency	(Fig.	1B).	This	identified	0.5%	as	the	minimum	concentration	of	158	 FA	that	fixes	cells	and	produces	high-MW	PAGE-impermeable	crosslinked	products.		As	159	 shown	by	immunoblotting,	crosslinking	results	in	a	tubulin	migrating	at	increasingly	160	 higher	MW	bands	in	a	FA-dependent	manner,	with	no	monomer	remaining	at	4%	FA	161	 (Fig.	1FS1A).	A	similar	FA-dependent	shift	is	observed	for	histone	H3	(Fig.	1FS1B).	162	 These	data	show	that	while	0.1%	FA	is	sufficient	to	observe	crosslinked	proteins,	4%	FA	163	
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is	required	to	crosslink	most	of	the	total	protein	pool.	However,	high	FA	concentrations	164	 reduce	the	efficiency	of	reverse-crosslinking,	as	discussed	below.		165	 To	test	the	efficiency	of	reverse-crosslinking,	FA-fixed	lysates	were	heated	at	95	166	 °C	for	30	min,	electrophoresed	under	reducing	conditions	and	total	protein	visualized	167	 by	SyproRuby	staining	(Fig.	1C).	The	17-kD	band	that	was	lost	in	a	FA	concentration-168	 dependent	manner	(Fig.	1B,	arrow),	was	recovered	upon	crosslink	reversal	(Fig.	1C,	169	 arrow).	However,	high	MW	bands,	indicated	by	an	asterisk,	are	still	observed	at	4%	FA	170	 after	heating.	Quantitation	of	the	summed	intensity	within	the	top	third	of	the	gel	171	 indicates	a	~20%	increase	in	intensity	in	4%	FA,	compared	with	0%	FA,	likely	due	to	172	 irreversibly	crosslinked	high	MW	protein-protein	complexes.	Consistent	with	the	Sypro	173	 Ruby	stain	data,	immunoblots	show	that	the	pools	of	crosslinked	a-tubulin	and	histone	174	 H3	multimers,	produced	by	treatment	of	cells	with	4%	FA,	are	heat	stable	(Fig.	1FS	175	 1C&D).		176	 Protein-DNA	crosslinks	created	by	FA	can	affect	the	accuracy	of	measuring	DNA	177	 content	by	flow	cytometry	and	thus	may	decrease	the	resolution	with	which	cell	cycle	178	 phases	can	be	separated.	We	measured	the	DNA	content	of	cells	fixed	with	the	indicated	179	 FA	concentrations,	permeabilised	with	70%	ethanol	and	stained	with	either	propidium	180	 iodide	(PI,	left),	or	with	4’,6-diamidino-2-phenylindole	(DAPI,	right),	(Fig.	1FS2).	181	 Hoechst-33342	gave	inferior	results	(data	not	shown).	PI	staining	of	cells	treated	with	182	 0%	FA	produces	low	coefficient-of-variation	(CV)	values,	e.g.	5.6%	for	G1,	which	183	 increase	in	a	FA	dose-dependent	manner.	Peaks	for	2N	and	4N	DNA	content	(i.e.,	G1	and	184	 G2&M	phases),	coalesce	at	1%	and	higher	concentrations	of	FA.	DAPI	showed	slightly	185	 higher	starting	CV	values	(7.3%	for	G1),	but,	unlike	PI,	was	minimally	affected	by	FA	186	 concentration.	We	conclude	that,	with	these	fixation	conditions,	0.5%	FA	is	the	187	 maximum	for	optimum	use	with	PI,	while	4%	FA	can	be	used	with	DAPI.	In	experiments	188	
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where	quantitation	of	DNA	content	by	PI	is	not	required	to	isolate	a	cell	subpopulation	189	 of	choice,	then	up	to	2%	FA	can	be	used	in	combination	with	the	intracellular	staining	190	 protocol,	with	minimal	protein	loss	(Fig.	1C).	191	 Quantitative	comparisons	of	protein	levels	using	stable	isotope	labeling	by	192	 amino	acids	in	cell	culture	(SILAC)(Ong	et	al.	2002),	are	internally	controlled,	thereby	193	 minimizing	the	effect	of	technical	variation	after	mixing	on	the	accuracy	of	quantitation.	194	 We	therefore	used	SILAC	to	evaluate	how	alternative	permeabilisation	reagents	affect	195	 proteome	recovery.		Importantly,	because	SILAC	quantitation	is	ratiometric	and	196	 internally	controlled,	quantitation	accuracy	is	not	significantly	dependent	on	potential	197	 protocol-dependent	differences	in	overall	proteome	coverage	achieved.		For	198	 compatibility	with	both	PI	and	DAPI	staining	and	efficient	crosslink	reversal,	cells	were	199	 fixed	with	0.5%	FA.	Three	protocols	were	compared	(Fig.	1D):	(i)	cells	were	fixed	and	200	 permeabilised	with	0.5%	Triton	X-100,	(ii)	cells	were	fixed	and	permeabilised	with	90%	201	 methanol	and	(iii)	cells	were	lysed	without	fixation	and	permeabilisation.	Cells	were	202	 then	mixed	pairwise	1:1	by	cell	count	and	processed	for	‘single	shot’	MS	analyses	203	 (Supplementary	File	1).		204	 The	log2-transformed	normalized	ratios	for	each	of	the	~1,235	proteins	205	 quantitated	in	all	three	conditions	were	compared	(Figs.	1E-G).	In	Fig.	1E,	the	position	206	 of	each	point	in	the	scatter	plot	relative	to	the	x-axis	represents	the	ratio	between	the	207	 abundance	of	a	single	protein	measured	in	cells	permeabilised	with	Triton	X-100,	208	 (method	i),	and	the	same	protein	in	cells	processed	by	lysis	only	(method	iii).	Points	are	209	 offset	on	the	y-axis	to	minimise	overplotting.	Proteins	detected	equally	in	each	method	210	 will	show	a	ratio	of	1,	while	irreversible	FA-induced	protein	modifications	and/or	losses	211	 due	to	permeabilisation	will	cause	lowered	ratios.	Proteins	annotated	with	the	212	
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subcellular	localization	GO	terms,	‘membrane’	and/or	‘mitochondrial’,	are	shown	in	213	 purple.		214	 Triton	X-100	is	widely	used	in	protocols	for	cell	permeabilisation	when	215	 immunostaining	intracellular	antigens.	However,	we	observe	that	many	proteins	(31%)	216	 are	depleted	in	Triton-X100-treated	cells	(Fig.	1E).	Proteins	showing	lower	ratios	after	217	 Triton-X100	permeabilisation	are	enriched	for	‘mitochondrial’	and/or	‘membrane’	GO	218	 terms	(Fisher’s	exact	test	for	enrichment:	p	<	1	x	10-25	for	mitochondria	and	p	<	1	x	10-20	219	 for	membrane	GO	annotations).	In	contrast,	a	comparison	of	methanol	permeabilisation	220	 with	direct	lysis	shows	that	most	proteins	(97%)	vary	<2-fold	(Fig.	1F).	However,	the	221	 levels	of	some	proteins	were	reduced	following	methanol	treatment.	To	investigate	222	 whether	this	was	stochastic,	we	compared	two	technical	replicates	of	methanol-223	 permeabilised	cells	using	SILAC	(Fig.	1G).	The	low	variance	between	the	replicates	(s.d.	224	 =	0.15)	indicates	that	the	effects	of	methanol	permeabilisation	on	protein	extraction	and	225	 measurement	efficiencies	are	systematic	and	reproducible.	However,	GO	annotation	226	 analysis	shows	no	significant	enrichment	for	the	proteins	with	decreased	abundance	227	 after	methanol	permeabilisation	(Fig.	1F).	The	reason	for	the	selective	protein	loss	is	228	 therefore	not	clear	but	is	unlikely	to	significantly	bias	downstream	proteome	analyses	229	 between	samples	that	have	been	similarly	methanol-treated.		230	 In	summary,	we	conclude	that	methanol	is	preferred	over	Triton-X100	as	a	231	 permeabilisation	reagent	for	downstream	proteome	analysis	under	these	fixation	232	 conditions.	233	 These	data	identify	a	protocol	for	immunostaining	intracellular	antigens	that	is	234	 compatible	with	efficient	downstream	MS-based	peptide	ID	and	quantitation	and	that	235	 minimizes	loss	of	protein	identifications.	While	the	fixation	and	permeabilisation	steps	236	 slightly	reduce	the	overall	peptide	signal	(Fig.	1F),	these	decreases	are	reproducible	and	237	
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can	be	accounted	for	in	performing	relative	comparisons	of	protein	abundance	(Fig.	1G).	238	 We	term	the	resulting	methodology	using	this	optimized	protocol,	‘PRIMMUS’	239	 (Proteomics	of	intracellular	immunostained	cell	subpopulations).	240	
PRIMMUS	analysis	of	protein	accumulation	across	the	cell	division	cycle	241	 The	PRIMMUS	methodology	is	well-suited	for	transforming	end-point	242	 immunostaining	flow	cytometry	assays	for	cell	cycle	analysis	into	a	preparative	243	 procedure	for	global	proteome	characterisation.	For	example,	G1,	S	and	G2&M	cell	244	 populations	can	be	distinguished	by	DNA	content	alone	using	flow	cytometry.	As	G2	and	245	 M	phase	cells	have	identical	DNA	content	and	similar	size	distributions,	an	additional	246	 parameter	is	required	to	separate	these	phases.	H3S10ph,	which	accompanies	mitotic	247	 chromatin	condensation	(Hendzel	et	al.	1997),	is	a	specific	marker	for	mitotic	cells	in	248	 many	cell	types	and	across	many	phyla	(Hans	&	Dimitrov	2001).	H3S10ph	staining	is	249	 often	used	as	a	proxy	for	mitotic	index,	particularly	in	flow	cytometry	assays	(Juan	et	al.	250	 1998).	The	specificity	of	the	anti-H3S10ph	antibody	for	mitotic	cells	also	aids	an	251	 evaluation	of	the	potential	effect	of	antibody	IgG	peptides	on	peptide	identification.	252	 SILAC-labeled	cells	were	fixed,	permeabilised,	immunostained	and	sorted	into	253	 four	subpopulations	(i.e.,	G1,	S,	G2,	and	M),	based	on	both	DNA	content	and	H3S10ph	254	 staining,	then	processed	for	MS	analysis,	as	illustrated	in	Fig.	2A.	Four	subpopulations	255	 are	discernable	in	a	representative	psuedocolour	scatter	plot	of	the	flow	cytometric	256	 analysis,	showing	H3S10ph	staining	(y-axis),	versus	DNA	content	(x-axis)	(Fig.	2B).	Cells	257	 were	sorted	into	G1,	S,	G2	and	M	fractions	using	the	sorting	‘gates’	indicated	(Fig.	2B,	258	 black	boxes).	The	purities	of	G2	and	M	fractions	were	validated	by	co-immunostaining	259	 fractionated	cells	with	anti-alpha	tubulin	antibodies	and	analysis	by	260	 immunofluorescence	(Fig.	2C).	This	showed	that	none	of	the	cells	in	the	G2	fraction	261	
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were	mitotic	and	>96%	of	cells	in	the	M	fraction	were	mitotic,	as	evaluated	by	262	 chromatin	condensation	and	microtubule	organization	(Fig.	2D).		263	 Relative	protein	abundances	among	the	four	sorted	subpopulations	of	cells	were	264	 determined	using	SILAC	quantitation	in	single	shot	MS	analyses	(Fig.	2E).	Flow	sorted	265	 “heavy”	cell	populations	were	mixed	with	equal	numbers	of	asynchronous	“light”	cells,	266	 with	the	signal	from	the	“light”	cells	used	as	an	internal	standard	to	compare	the	four	267	 sorted	populations	(Fig.	2E).	Four	biological	replicates	were	performed.	268	 In	total,	32,066	peptides	were	identified	from	the	four	replicate	experiments	269	 (raw	data	available	at	the	ProteomeXchange	Consortium	partner	PRIDE,	identifier	270	 PXD007787).	These	peptide	measurements	enabled	quantitation	of	3,696	proteins,	of	271	 which	3,162	have	at	least	two	supporting	peptides	per	protein	(Supplementary	File	2).	272	 A	comparable	number	of	proteins	were	identified	when	the	identical	single	shot	MS	273	 analysis	was	performed	on	a	standard	complex	peptide	mixture	prepared	from	directly	274	 lysed	human	NB4	cells	(Ly	et	al.	2014).	All	cells	in	the	asynchronous	population	are	275	 exposed	to	the	H3S10ph	antibody,	yet	only	M-phase	cells	carry	the	antigen	and	are	276	 immunostained.	Thus,	the	recovered	M	phase	fractions	will	have	IgG	proteins	that	will	277	 be	largely	absent	in	the	other	fractions.	Peptide	ID	and	quantitation	rates	are	similar	278	 across	sorted	populations	(Fig.	2F),	suggesting	that	antibody-derived	peptides	present	279	 in	the	cell	extracts	from	the	M-phase	fraction	do	not	significantly	hinder	the	MS-based	280	 peptide	ID	rate.	Known	FA-induced	modifications,	such	as	methylol	and	Schiff	base	281	 intermediates	(producing	+30	and	+12	mass	shifts,	respectively),	were	identified	after	282	 adding	these	modifications	to	the	search	database.	However,	only	a	small	number	of	283	 peptides	(<1%)	were	found	to	be	modified	(Fig.	2	Fig.	Supp.	1).	284	 Because	the	SILAC	mixing	was	performed	using	equal	numbers	of	cells	from	each	285	 population,	rather	than	equal	amounts	of	protein	(as	determined	e.g.	by	mass	or	286	
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concentration),	the	ratios	measured	here	reflect	the	variation	in	average	protein	287	 abundance	at	the	respective	G1,	S,	G2	and	M	phases	during	an	unperturbed	cell	division	288	 cycle.	Fig.	3A	shows	a	modified	violin	plot	(here,	called	a	‘neeps’	plot)	of	log2	ratios	289	 versus	sort	population	(G1,	S,	G2	and	M).	The	width	of	each	‘neep’	is	proportional	to	the	290	 number	of	proteins.	Black	lines	mark	quartiles	and	shading	indicates	interquartile	291	 ranges.	Compared	with	the	internal	standard	(asynchronous	cells),	G1	cells	have	a	292	 median	ratio	of	~0.8	and	mitotic	cells	a	median	ratio	of	~1.3.	Thus,	an	average	M	phase	293	 cell	contains	~1.6x	the	number	of	protein	molecules	present	in	an	average	G1	cell.	This	294	 value	is	less	than	2	(the	approximate	ratio	theoretically	expected	between	a	newly	295	 divided	cell	and	a	mitotic	cell),	because	the	‘average’	G1	cell	has	already	spent	several	296	 hours	in	G1	phase,	during	which	time	new	protein	synthesis	has	commenced.	297	 Using	the	average	doubling	time	for	NB4	cells	(24	hours)	and	the	frequency	of	298	 cells	in	each	cell	cycle	phase,	as	measured	by	flow	cytometry	(21%,	65%,	92%	and	98%,	299	 for	G1,	S,	G2,	and	M,	respectively,	from	N	=	5),	we	used	ergodic	analysis	(Pozarowski	&	300	 Darzynkiewicz	2004;	Wheeler	2015;	Kafri	et	al.	2013)	to	estimate	the	average	time	301	 post-division	for	each	subset	of	cells	and	express	them	as	a	fraction	of	the	total	cell	302	 division	time,	i.e.	t	=	0	(newly	divided),	t	=	0.16	(G1),	t	=	0.57	(S),	t	=	0.89	(G2),	t	=	0.98	303	 (M)	and	t	=	1.0	(cell	division).	This	representation	of	the	relative	cell	cycle	division	time	304	 (Fig.	3B,	inset),	allows	protein	abundance	data	to	be	plotted	on	a	numerical	time	axis	305	 and	provides	a	quantitative	measurement	of	protein	accumulation	across	the	cell	cycle.		306	 Global	changes	in	relative	protein	abundance	at	different	cell	cycle	stages	were	307	 estimated	by	taking	the	mean	log2	SILAC	measurement	across	all	proteins.	Mean	protein	308	 measurements	were	calculated	for	each	cell	cycle	phase,	normalized	to	G1	and	plotted	309	 as	a	function	of	cell	division	time,	with	error	bars	indicating	the	standard	error	of	the	310	 mean	(Fig.	3B).	Bulk	protein	abundance	accumulation	across	the	cell	cycle	follows	an	311	
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exponential	growth	curve	(r2	=	0.99)	(Fig.	3B).	Bulk	protein	abundance	is	measured	to	312	 increase	~1.9-fold	between	a	newly	divided	cell	and	a	cell	about	to	enter	the	next	313	 mitosis	phase.	These	findings	are	consistent	with	results	from	experiments	performed	314	 decades	ago,	using	radioactive	pulse-chase	experiments	to	analyse	bulk	protein	315	 accumulation	(Scharff	&	Robbins	1965),(Rønning	et	al.	1979).	However,	using	316	 PRIMMUS,	the	relative	protein	accumulation	across	the	cell	cycle	is	measured	here	not	317	 on	bulk	protein	alone,	but	rather	on	a	per-protein	basis	for	thousands	of	individual	318	 proteins.		319	 We	exploited	the	per-protein	resolution	of	our	data	to	examine	whether	different	320	 protein	classes	accumulate	at	different	rates	during	the	cell	cycle.	Fig.	3C	shows	a	321	 heatmap	summarising	an	analysis	of	the	mean	normalized	ratio	for	proteins	with	GO	322	 annotations	for	major	cellular	processes,	i.e.,	transcription,	mRNA	splicing,	translation,	323	 DNA	replication	and	mitosis	(Fig.	3C).	Proteins	involved	in	DNA	replication	increase	324	 more	on	average	during	S	phase	than	proteins	involved	in	basal	gene	expression	(mRNA	325	 splicing,	cellular	metabolism,	translation).	In	contrast	to	most	functional	protein	326	 categories	measured,	sphingolipid	metabolism	and	cellular	defense	response	proteins	327	 remain	relatively	constant	across	the	cell	division	cycle.		328	 We	show	individual	profiles	for	selected	proteins	in	Fig.	3D.	Aurora	kinase	A,	329	 which	regulates	spindle	assembly	in	mitosis	(Floyd	et	al.	2008),	increases	in	abundance	330	 by	more	than	8-fold	between	G1	and	M	phase	(Fig.	3D).	Core	histones,	however,	show	a	331	 profile	that	resembles	bulk	protein	accumulation	and	approximately	double	in	332	 abundance	across	the	cell	cycle,	consistent	with	the	parallel	doubling	in	DNA	content.	333	 However,	while	bulk	protein	continues	to	accumulate	between	G2	and	M	(Fig.	3D),	334	 histone	abundance	remains	relatively	flat,	consistent	with	histone	protein	synthesis	335	 being	markedly	down-regulated	once	S	phase	is	completed	(Fig.	3D).	Interestingly,	in	336	
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contrast	with	bulk	cellular	proteins,	we	note	that	proteins	involved	in	stress	responses	337	 and/or	apoptosis,	such	as	p53,	NKAP	(a	member	of	the	NF-kappa	B	pathway)	and	the	338	 apoptotic	regulators	BAX	and	BID,	remain	relatively	constant	on	a	per-cell	basis	across	339	 these	four	cell	subpopulations.		340	 Using	FACS,	each	cell	cycle	phase	is	enriched	with	higher	purity	as	compared	341	 with	centrifugal	elutriation.	We	therefore	analysed	whether	this	results	in	the	PRIMMUS	342	 method	providing	increased	sensitivity	for	detecting	relative	changes	in	protein	343	 abundance	between	cell	cycle	phases.	Fig.	3E	shows	a	comparison	between	datasets	344	 obtained	using	either	PRIMMUS	(red	circles),	or	elutriation	(blue	triangles).	These	14	345	 proteins	all	peak	in	abundance	in	G2&M	relative	to	G1	phases,	show	the	highest	G2&M	346	 vs.	Async	ratios	in	the	elutriation	dataset,	and	are	annotated	with	‘cell	cycle’	gene	347	 ontology	terms	(i.e.,	CDC20,	AURKA,	KIFC1,	CCNB1,	ANLN,	HMMR,	KIF20A,	AURKB,	348	 CCNB2,	RRM2,	PLK1,	RACGAP1,	CENPF	&	PRC1).	All	14	proteins	show	higher	ratios	in	349	 the	PRIMMUS	dataset.	We	conclude	that	the	higher	enrichment	purities	for	cell	subsets	350	 obtained	by	FACS	results	in	PRIMMUS	providing	a	sensitivity	advantage	over	centrifugal	351	 elutriation.		352	
PRIMMUS	analysis	of	protein	phosphorylation	across	interphase	and	mitosis	353	 	 While	formaldehyde-induced	modifications	are	generally	low	(see	above),	the	354	 frequent	reliance	on	single	phosphopeptides	for	quantitation	in	phosphoproteomics	355	 means	that	phosphopeptide	detection	may	be	more	challenging	with	fixed	samples.	We	356	 therefore	assessed	whether	the	PRIMMUS	workflow	was	detrimental	to	357	 phosphopeptide	analysis.	Lysates	were	generated	from	untreated	cells	and	from	cells	358	 processed	using	PRIMMUS.	Proteins	were	precipitated,	digested	with	LysC	and	Trypsin,	359	 and	subjected	to	Ti:IMAC	phospho-enrichment	in	technical	triplicate,	on	different	days.	360	 Enriched	phosphopeptides	were	analysed	using	2-hr	LC-MS	analyses	detecting	in	total	361	
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6,587	phosphorylation	sites	and	a	mean	of	~2,000	phosphorylation	sites	per	individual	362	 analysis.	Fig.	4	–	Fig.	Supp.		1	shows	a	comparison	of	phosphopeptide	detection	rates	363	 between	control	cells	and	cells	processed	for	PRIMMUS	analysis.	No	significant	364	 difference	between	the	phosphopeptide	identification	rate	was	measured	(p	>	0.05,	N	=	365	 3).		366	 We	next	investigated	protein	phosphorylation	changes	during	interphase	and	367	 mitosis	using	PRIMMUS.	Using	the	identical	sort	strategy	as	above,	we	separated	368	 asynchronous	NB4	cells	into	G1,	S,	G2	and	M	phase	fractions	by	FACS	(Fig.	4A).	The	369	 experiment	was	performed	in	biological	duplicate.	The	cell	fractions	were	then	370	 processed	for	phosphopeptide	analysis	and	TMT-based	quantitation	(8-plex,	2	371	 biological	replicates	x	4	cell	cycle	phase	fractions).	Enriched	phosphopeptides	with	no	372	 further	peptide	fractionation	were	detected	and	quantitated	using	a	single	shot	LC-373	 MS/MS	analysis.	In	total,	4,500	phosphorylation	sites	were	identified	on	1,558	proteins.	374	 Most	phosphorylation	sites	were	phosphoserines	(83.2%),	with	smaller	frequencies	for	375	 phosphothreonines	(15.8%)	and	phosphotyrosine	(1.0%)	(Fig.	4B).	Over	60%	of	the	376	 phosphorylation	sites	matched	the	proline-directed	kinase	motif	(S/T	followed	by	a	377	 proline	(Fig.	4C).	CDKs	and	MAP	kinases	can	phosphorylate	the	[S/T]P	motif	(as	378	 reviewed	in	(Amanchy	et	al.	2007)).	The	phosphoproteins	detected	are	enriched	in	379	 proteins	with	functions	in	cell	division	and	DNA	repair/stress	response,	in	addition	to	380	 ‘housekeeping’	proteins	involved	in	gene	expression	(Fig.	4D).	The	phosphorylation	site	381	 abundance	profiles	for	the	duplicate	measurements	were	similar	(Fig.	4E).	As	discussed	382	 in	more	detail	below,	many	of	the	extreme	differences	in	phosphorylation	are	observed	383	 in	the	mitotic	fraction.	Pearson	correlations	calculated	for	individual	phosphorylation	384	 sites	showed	high	correlation	(Fig.	4F).	The	maximum	fold	changes	measured	for	385	
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individual	phosphorylation	sites	were	also	highly	correlated	between	the	two	386	 replicates,	showing	that	the	quantitation	was	reproducible	(Fig.	4G).		387	 	 The	identified	phosphorylation	sites	were	then	clustered	using	k-means	into	six	388	 groups	(Fig.	5A).	Cluster	1	contains	phosphorylation	sites	that	rise	significantly	during	389	 mitosis.	Interestingly,	many	of	these	sites	also	show	an	increase	in	the	G2	fraction	(Fig.	390	 5A,	arrow).	We	note	that	a	similar	trend	is	observed	when	phosphorylation	changes	are	391	 normalized	to	protein	abundance	changes	(Fig.	5	Fig.	Supp.	1).	Clusters	that	peak	in	392	 mitosis	(1,	2,	3	and	5)	represent	34%	of	the	phosphorylations	quantitated	(Fig.	5B).	393	 Interestingly,	this	number	is	significantly	smaller	than	reported	previously	in	a	study	394	 measuring	phosphorylation	dynamics	in	HeLa	cells	synchronized	using	nocodazole	395	 arrest	and	arrest-release	protocols	(Olsen	et	al.	2010).	A	comparison	of	the	ratios	396	 measured	for	the	same	phosphorylation	sites	identified	in	the	PRIMMUS	dataset	and	in	397	 this	previous	analysis	in	synchronized	HeLa	cells	shows	significant	differences.	398	 Phosphorylation	sites	upregulated	in	both	datasets	are	on	proteins	enriched	for	the	399	 gene	ontology	annotations	‘cell	cycle’	and	‘mitosis’.	We	note	that	a	similar	enrichment	400	 for	‘cell	cycle’	annotations	was	found	for	proteins	whose	phosphorylation	sites	401	 specifically	upregulated	in	this	PRIMMUS	dataset	(Fig.	5C,	purple),	which	was	402	 performed	using	NB4	cells.	In	contrast,	phosphorylation	sites	specifically	upregulated	in	403	 the	previous	HeLa	cell	arrest-release	dataset	(which	are	not	changing	in	this	PRIMMUS	404	 dataset),	are	instead	on	proteins	showing	significant	enrichment	for	the	gene	ontology	405	 annotation	‘RNA	splicing	function’	and	show	no	enrichment	for	either	‘mitosis’,	or	‘cell	406	 cycle’	(Fig.	5C,	cyan).	These	differential	enrichments	in	specific	cellular	functions	for	the	407	 proteins	identified	with	changing	levels	of	phosphorylation	across	the	cell	cycle	suggest	408	 underlying	physiological	differences	between	the	cells	used	in	these	respective	studies	409	 (see	also	Discussion).		410	
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Identification	of	a	set	of	‘early	rising’	phosphorylation	sites	411	 	 While	most	of	the	significantly	changing	phosphorylation	sites	peak	in	mitosis,	a	412	 subset,	consisting	of	115	sites,	also	show	significantly	increased	phosphorylation	in	the	413	 G2	phase	enriched	fraction.	We	have	termed	these	115	phosphorylation	sites,	‘early	414	 risers’.	The	high	enrichment	efficiency	of	FACS	(c.f.	Fig.	2C)	renders	it	very	unlikely	that	415	 the	increased	G2	ratios	measured	originate	from	contamination	from	H3S10ph-positive	416	 mitotic	cells	in	the	G2-enriched	fraction.	Indeed,	further	analysis	shows	that	early	risers	417	 share	additional	functional	similarities.	Thus,	early	rising	phosphorylation	sites	are	418	 situated	on	proteins	highly	enriched	in	nuclear,	nuclear	envelope	and	chromatin	419	 localisations	using	identified	phosphoproteins	as	‘background’(Fig.	6A).		420	 A	STRING	network	analysis	(Fig.	6B)	identifies	several	functional	categories	of	421	 early	rising	proteins,	including	DNA	replication,	cytoskeleton	remodelers	and	422	 spindle/kinetochore	components,	chromatin	factors	and	remodelers,	nuclear	envelope	423	 proteins,	transcription	factors,	nucleolar	proteins	and	mRNA	capping	proteins.	Proteins	424	 with	the	highest	ranked	ratios	are	either	involved	in	DNA	replication,	or	associated	with	425	 the	nuclear	envelope	(Supplementary	File	2).	Motif	analysis	(Chou	&	Schwartz	2002)	426	 shows	that	early	risers	are	enriched	in	the	optimal	CDK	consensus	motif	of	a	427	 serine/threonine	followed	by	a	proline	and	a	downstream	basic	residue	(Fig.	6C).	428	 Consistent	with	a	high	CDK	phosphorylation	propensity,	early	risers	on	average	have	429	 higher	phosphorylation	ratios	during	M-phase	compared	to	‘late	risers’	(Fig.	6D),	i.e.	430	 late	risers	being	defined	as	phosphorylation	sites	that	peak	in	mitosis	and	do	not	431	 increase	in	G2.		432	 	 One	of	the	early	risers	identified	was	on	the	protein	TPX2.	Two	TPX2	433	 phosphorylation	sites	are	quantitated	in	this	dataset,	i.e.,	S185	and	S738.	Both	sites	have	434	 surrounding	sequences	matching	the	consensus	CDK	phosphorylation	motif	(SPEK	and	435	
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SPK,	respectively)	and	show	increased	phosphorylation	in	the	G2-phase	enriched	436	 fraction,	compared	with	the	total	levels	of	unmodified	TPX2	protein	((Ly	et	al.	2014)).	437	 However,	TPX2	S738	is	an	early	riser	site	that	is	phosphorylated	to	a	greater	extent	in	438	 the	G2	phase	fraction	and	this	difference	is	further	increased	in	the	M-phase	fraction.	439	 We	therefore	decided	to	explore	whether	there	was	any	functional	relevance	for	440	 phosphorylation	of	TPX2	at	S738	in	mammalian	cells	by	analysis	of	phosphodefective	441	 and	phosphomimetic	mutants.		442	
Expression	of	S738A	TPX2	mutant	fails	to	rescue	TPX2-depleted	cells	443	 	 To	assess	the	potential	function	of	TPX2	phosphorylation	at	serine	738,	the	444	 mitotic	phenotype	of	porcine	LLC-Pk1	cell	lines	expressing	TPX2	or	TPX2,	comparing	445	 also	proteins	with	either	phosphodefective	(738A)	or	phosphomimetic	(738D)	point	446	 mutations	was	analyzed.		A	mouse	bacterial	artificial	chromosome	(BAC)	expressing	447	 wild	type	TPX2	with	a	GFP	tag	was	mutated	to	generate	either	TPX2-738A-GFP,	or	448	 TPX2-738D-GFP	versions	of	the	protein	and	cell	lines	expressing	each	of	the	constructs	449	 were	generated.				To	examine	spindle	phenotypes,	endogenous	porcine	TPX2	was	450	 depleted	using	siRNA	(Ma	et	al.	2011)	and	spindle	morphology	was	scored	in	either	live,	451	 or	fixed	cells	(Fig.	7).	452	 Consistent	with	prior	work,	depletion	of	TPX2	from	parental	cells	resulted	in	a	453	 collapsed	spindle	phenotype	characterized	by	two	large	asters	with	a	short	intervening	454	 spindle	(Gruss	et	al.	2002).	Spindles	in	cells	treated	with	a	non-specific	siRNA	were	455	 nearly	all	bipolar	(Fig.	7).		Expression	of	either	of	the	mutant	forms	of	TPX2	resulted	in	456	 defects	in	spindle	morphology	including	monopolar,	multipolar,	bent	and	misshapen	457	 spindles	(collectively	referred	to	as	“other”,	Fig.	7)	as	well	as	collapsed	spindles.		The	458	 results	show	a	decrease	in	the	percentage	of	bipolar	spindles	and	increase	in	defective	459	
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spindles	for	both	mutations;	neither	phenotype	was	as	severe	as	cells	treated	with	460	 siRNA	targeting	TPX2	alone	(Fig.	7).	461	 To	further	examine	the	consequences	of	mutation	at	serine	738	in	more	detail,	462	 time	lapse	imaging	of	cells	expressing	either	wild-type,	or	mutant	TPX2,	and	treated	463	 with	siRNA	targeting	porcine	TPX2,	was	performed;	only	cells	that	completed	mitosis	464	 during	the	imaging	period	were	scored.		Although	the	mitotic	duration	of	the	465	 phosphodefective	738A	mutant	was	not	different	from	that	of	cells	expressing	the	wild	466	 type	protein,	a	mitotic	delay	was	observed	in	cells	expressing	the	phosphomimetic	467	 version	of	TPX2	consistent	with	a	role	for	the	site	in	mitotic	progression	(Fig.	7).	468	 Because	the	TPX2-738	phosphorylation	site	was	classified	as	an	early	riser,	a	469	 defect	early	in	mitosis	might	be	expected.		TPX2	is	nuclear	throughout	interphase,	470	 although	a	small	fraction	of	the	protein	can	be	detected	outside	the	nucleus,	at	the	471	 centrosome,	in	prophase	(Ma	et	al.	2011;	Vos	et	al.	2008);	however,	the		contribution	of	472	 TPX2	to	the	events	of	early	mitosis	is	not	yet	established.		Defects	in	mitotic	progression	473	 prior	to	NEBD	would	be	not	be	detected	in	our	time-lapse	imaging.		However,	the	474	 observed	spindle	defects	are	consistent	with	deficiencies	in	spindle	formation	and	a	475	 contribution	of	the	TPX2-738	site	to	mitosis	in	live	cells.	476	
PRIMMUS	analysis	of	protein	abundance	variation	during	mitosis	477	 We	next	used	the	PRIMMUS	method	to	perform	a	proteomic	analysis	of	protein	478	 abundance	variation	across	four	temporally	distinct	stages	of	mitosis,	reflecting	479	 prophase,	prometaphase	(1	&	2,	see	below)	and	anaphase.	We	aimed	to	screen	for	480	 proteins	that	show	abundance	patterns	resembling	cyclins	A	and	B,	which	could	reveal	481	 novel	targets	whose	degradation	is	also	regulated	during	mitosis.	We	chose	H3S28ph	482	 and	cyclin	A	(CycA),	as	two	markers	with	which	to	distinguish	different	mitotic	483	 subphases.	Like	H3S10ph,	the	H3S28ph	signal	is	associated	with	chromatin	484	
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condensation	(as	reviewed	in	(Hans	&	Dimitrov	2001)).	During	mitosis,	cells	undergo	485	 reversible	condensation	of	chromatin,	with	highest	levels	of	compaction	observed	486	 during	prometaphase	and	metaphase	(Hans	&	Dimitrov	2001).	Thus,	cells	showing	the	487	 highest	levels	of	H3S28ph	signal	(H3S28ph-high),	represent	prometaphase	and	488	 metaphase	cells,	while	cells	showing	intermediate	levels	of	H3S28ph	signal	(H3S28ph-489	 mid),	are	in	early	(prophase)	and	late	(anaphase	and	telophase),	stages	of	mitosis,	490	 respectively.	Meanwhile,	CycA	is	targeted	for	degradation	by	the	APC/C	during	491	 prometaphase	in	a	SAC-independent	manner	(Elzen	&	Pines	2001).	Thus,	comparing	492	 either	the	presence,	or	absence,	of	CycA	provides	a	means	for	distinguishing	between	493	 ‘early’	(prometaphase	and	before)	vs.	‘late’	(prometaphase	and	after)	mitotic	cells,	494	 respectively.	Consistent	with	this,	flow	cytometry	analysis	of	cells	co-immunostained	for	495	 H3S28ph	and	CycA	show	four	subpopulations	(labelled	P1	–	P4),	which	are	H3S28ph	496	 positive	(Fig.	8A).	497	 The	four	subpopulations	described	above	were	isolated	by	FACS	and	analysed	by	498	 immunofluorescence	microscopy	(representative	images	are	shown	in	Fig.	8A,	right).	499	 The	frequency	of	interphase,	prophase,	prometaphase,	anaphase	and	telophase	cells	500	 were	each	measured,	with	at	least	100	cells	counted	for	each	subpopulation	(Fig.	8B).	501	 This	confirms	that	high	enrichment	efficiencies	were	obtained	for	prophase,	502	 prometaphase	and	anaphase,	respectively.	Telophase	and	cytokinesis	cells	were	not	503	 observed	in	these	subpopulations.	We	note	that	the	gating	strategy	employed,	which	504	 removes	potential	doublets	from	the	analysis,	biases	against	these	cells	(unpublished	505	 observations).	Fig.	8C	shows	a	representative	image	of	the	P4	subpopulation,	showing	506	 high	enrichment	of	anaphase	cells.	Based	on	these	high	enrichment	efficiencies,	we	have	507	 relabeled	these	populations	according	to	the	major	enriched	phase	represented,	i.e.,	508	
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prophase	(Pro),	prometaphase	1	(PM1),	prometaphase	2	(PM2)	and	anaphase	(Ana),	509	 respectively.	510	 The	FACS	protocol	was	repeated,	using	three	separate	asynchronous	cell	511	 populations	cultured	and	harvested	on	different	days.	Two	of	these	populations	were	512	 metabolically-labelled	with	stable	isotope	labelled	amino	acids	for	SILAC-based	relative	513	 quantitation.	These	populations	were	sorted	into	the	four	subpopulations,	P1	–	P4,	as	514	 described	above.	A	third	population	was	cultured	using	regular	culture	media	515	 containing	non-dialysed	bovine	serum.	For	this	third	experiment,	two	other	516	 subpopulations	were	collected,	i.e.,	G2	cells	(i.e.,	4N	DNA	content	and	pH3	negative	517	 cells)	and	M-phase	cells	(4N	DNA	content	and	pH3	positive	cells),	in	addition	to	the	P1	–	518	 P4	populations.	Relative	quantitation	was	performed	using	6-plex	peptide	TMT	labeling	519	 (Thompson	et	al.	2003).	To	maximize	peptide	recovery	for	MS	analysis,	the	SP3	520	 paramagnetic	bead	cleanup	method	was	used	(Hughes	et	al.	2014).	SILAC	samples	were	521	 analysed	using	a	Q-Exactive	Plus,	as	previously	described	(Endo	et	al.	2017).	TMT	522	 samples	were	analysed	using	a	Fusion	Tribrid	instrument,	using	synchronous	precursor	523	 selection	(SPS)	(McAlister	et	al.	2014)	to	minimize	ratio	compression.		Thus,	two	524	 distinct	relative	quantitation	strategies	were	employed	to	reduce	the	likelihood	that	any	525	 potential	artefacts	from	a	single	quantitation	strategy	would	systematically	bias	the	526	 dataset.	527	 Quantitative	data	for	>8,700	proteins	were	obtained	in	the	combined	dataset	528	 across	three	biological	replicates.	5,205	proteins	(60%)	were	detected	in	both	the	TMT	529	 and	SILAC	datasets.	To	identify	proteins	whose	abundance	changed	significantly,	530	 protein	profiles	were	calculated	based	on	the	mean	of	the	three	biological	replicates	and	531	 ratios	calculated,	relative	to	prophase	levels.	Proteins	showing	missing	values	in	any	of	532	 the	four	mitotic	subpopulations	were	discarded,	leaving	5,340	proteins.	A	maximum	533	
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fold	change	was	calculated	and	cutoffs	were	established	using	Z-scores	(~1.8-fold	at	534	 95%	confidence),	which	identified	235	proteins	meeting	this	cutoff.	Positive	correlation	535	 between	any	two	biological	replicates	was	used	as	a	second	criterion	for	significance,	536	 with	136	proteins	meeting	these	criteria	(Fig.	8E).	Several	proteins	were	excluded	from	537	 the	analysis	due	to	missing	values,	which	is	a	known	technical	issue	with	data-538	 dependent	acquisition.	However,	an	alternative,	non-mutually	exclusive	explanation,	is	539	 the	lack	of	detection	reflects	that	the	levels	of	these	proteins	fall	below	the	detection	540	 limit	due	to	physiological	down-regulation.	We	reasoned	that	the	latter	explanation	is	541	 more	likely	when	proteins	show	missing	values	reproducibly	in	a	single	fraction.	Two	542	 proteins	met	this	criterion	and	were	added	to	the	candidate	list	(Supplementary	File	4),	543	 which	now	totals	138	proteins.	However,	these	two	proteins	were	excluded	in	further	544	 clustering	analysis	due	to	missing	values	being	incompatible	with	the	standard	k-means	545	 clustering	algorithm.	Most	proteins	measured	(n	=	5,202,	~98.5%)	showed	no	546	 significant	change	(Fig.	8E).		547	 The	mean	profiles	for	the	136	proteins	showing	the	most	significantly	changing	548	 abundance	levels	were	clustered	using	k-means,	with	the	number	of	initial	clusters	(n	=	549	 12)	determined	using	a	within-cluster	sum-of-squares	analysis.	Because	we	were	550	 interested	in	identifying	candidates	for	targeted	protein	degradation	during	mitosis,	we	551	 focused	on	clusters	where	a	decrease	in	protein	abundance	was	evident.	These	were	552	 manually	agglomerated	into	three	clusters,	based	on	the	phase	in	which	the	decrease	is	553	 observed	(Fig.	8F).	Most	proteins	(79%),	show	a	decrease	in	abundance	coincident	with	554	 the	CycA+	prometaphase	subpopulation	(PM1),	with	fewer	proteins	(16%),	decreasing	555	 in	anaphase	and	fewer	still	(5%)	decreasing	in	the	CycA-	prometaphase	subpopulation	556	 (PM2).	557	
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We	next	examined	the	mean	protein	abundance	profiles	for	cyclins	A	and	B	(Fig.	558	 9A,	s.d.	shown	as	a	gray	ribbon).	As	expected	from	the	flow	cytometry	analysis	and	the	559	 sorting	strategy	employed,	cyclin	A2	shows	high	levels	in	Pro	and	PM1	and	a	marked	560	 decrease	in	PM2	and	Ana.	Two	isoforms	of	cyclin	B	are	detected	(B1	and	B2).	The	561	 abundances	of	both	isoforms	remain	relatively	constant	between	Pro,	PM1	and	PM2	and	562	 decrease	in	Ana	to	25-35%	of	prophase	levels.	These	data	are	consistent	with	the	563	 targeting	of	cyclin	B	for	degradation	by	the	APC/C	at	the	metaphase	to	anaphase	564	 transition.	In	contrast,	the	abundance	of	GAPDH,	a	protein	that	is	not	expected	to	be	565	 targeted	for	degradation	during	mitosis,	is	unchanged	between	these	subpopulations.		566	
RRM2	is	degraded	during	prometaphase	via	a	MLN-4924-sensitive	proteasomal	pathway	567	 We	were	interested	in	examining	other	proteins	that	co-clustered	with	the	cyclin	568	 proteins.	In	the	literature,	there	are	few	examples	of	substrates	targeted	for	degradation	569	 during	prometaphase,	as	compared	with	anaphase.	We	are	aware	of	only	two	proteins,	570	 cyclin	A2	and	Nek2,	for	which	there	is	significant	evidence	in	the	literature	for	targeted	571	 degradation	during	prometaphase(van	Zon	&	Wolthuis	2010).	Our	data	show	3	572	 additional	proteins	clustering	together	with	cyclin	A2,	i.e.,	ATAD2,	GMNN	and	RRM2.	573	 Inspection	of	the	protein	abundance	profiles	show	that	while	GMNN	levels	decrease	574	 during	prometaphase	to	~60%	of	prophase	levels,	a	second	major	decrease	in	GMNN	575	 abundance	occurs	during	anaphase,	where	its	levels	drop	to	~20%.	ATAD2,	a	protein	576	 involved	in	transcriptional	co-activation	of	cell	cycle	genes,	such	as	c-myc,	cyclin	D1	and	577	 E2F1,	shows	~50%	reduction	during	prometaphase.	ATAD2	contains	a	conserved,	578	 canonical	D-box	motif	situated	in	a	disordered	linker	region	between	a	predicted	DNA-579	 binding	bromo-	domain	and	a	second	globular	domain.	ATAD2	was	also	recently	shown	580	 to	be	cell	cycle	regulated	via	co-immunostaining	of	FUCCI-expressing	cells	with	a	rabbit	581	 polyclonal	antibody	recognizing	ATAD2	(Human	Protein	Atlas,	www.proteinatlas.org).		582	
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We	investigated	further	the	observed	down-regulation	of	RRM2.	RRM2	is	an	583	 essential	(Wang	et	al.	2015),	cell	cycle	regulated	subunit	of	ribonucleotide	reductase	584	 that	regulates	the	cellular	deoxyribonucleotide	pool	(Nordlund	&	Reichard	2006).	585	 Properly	timed	degradation	of	RRM2	has	been	suggested	to	be	important,	because	586	 disrupting	the	normal	degradation	timing	for	RRM2	leads	to	genomic	instability	587	 (D'Angiolella	et	al.	2012).	RRM2	has	been	shown	to	be	targeted	for	degradation	by	the	588	 APC/C-Cdh1	(Chabes	et	al.	2003)	and	Cyclin	F/SCF	(D'Angiolella	et	al.	2012)	complexes	589	 during	anaphase/G1	and	G2,	respectively.	Therefore,	we	were	surprised	to	observe	590	 significant	decreases	in	RRM2	abundance	during	prometaphase,	coincident	with	591	 degradation	of	cyclin	A2	(Fig.	9B).	592	 A	rabbit	polyclonal	antibody	recognising	human	RRM2,	generated	by	the	Human	593	 Protein	Atlas,	was	evaluated	for	specificity	by	either	siRNA	depletion	of	RRM2,	or	594	 overexpression	of	a	RRM2-GFP	construct.	(Fig.	9	Fig.	Suppl.	1).	As	shown	by	both	flow	595	 cytometry	and	western	blot	analysis,	depletion	of	RRM2	significantly	reduces	or	596	 abolishes	the	antibody	signal,	and	GFP	and	anti-RRM2	staining	patterns	show	high	597	 correlation	by	immunofluorescence.	Combined	immunohistochemistry	and	RNA-Seq	598	 analysis	across	multiple	human	tissues	show	that	antibody	staining	is	correlated	with	599	 the	cognate	RRM2	mRNA	(Human	Protein	Atlas,	600	 http://www.proteinatlas.org/ENSG00000171848-RRM2/tissue).	This	validated	RRM2	601	 antibody	was	used	to	measure	the	levels	of	RRM2	across	the	cell	cycle	in	both	NB4	and	602	 U2OS	cells.	Consistent	with	its	degradation	by	APC/C-Cdh1,	flow	cytometry	analysis	of	603	 RRM2	levels	and	DNA	content	in	NB4	cells	show	that	RRM2	levels	are	low	during	G1	604	 phase	and	increase	significantly	during	S-phase,	reaching	a	peak	in	G2&M	(Fig.	9C).	605	 Consistent	with	the	data	in	NB4	cells,	immunostaining	in	FUCCI	U2OS	also	shows	that	606	 RRM2	abundance	peaks	in	G2	phase	(Fig.	9	Fig.	Suppl.	2).	Interestingly,	in	both	these	607	
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analyses,	RRM2	levels	do	not	show	a	significant	decrease	in	G2	(D'Angiolella	et	al.	608	 2012).	Co-immunostaining	cells	to	detect	both	cyclin	A	and	H3S28ph	enables	a	flow	609	 cytometry-based	comparison	of	RRM2	levels,	using	the	same	gating	strategy	as	the	MS-610	 based	analysis	used	to	define	subpopulations.	A	separate	control	sample,	using	an	611	 antibody	recognizing	alpha	tubulin,	was	included	as	a	negative	control.	Fig.	9D	shows	612	 the	fluorescence	signal	distributions	for	two	subpopulations	marked	by	H3S28ph	and	613	 CycA	staining:	i.e.,	CycA+	prometaphase	(PM1)	versus	CycA-	prometaphase	(PM2)	cells.	614	 Comparing	protein	levels	in	the	respective	PM1	vs	PM2	subpopulations,	alpha	tubulin	615	 shows	no	change,	as	expected	(Fig.	9D,	left).	In	contrast,	the	level	of	RRM2	in	PM2	is	616	 markedly	decreased,	as	compared	with	PM1,	consistent	with	the	MS-based	quantitation	617	 (Fig.	9D,	right).	RRM2	levels	during	mitosis	were	independently	measured	in	U2OS	cells	618	 by	co-immunostaining	with	Cyclin	B1	and	RRM2	antibodies	(Fig.	9	Fig	Supp.	3).	A	619	 decrease	in	RRM2	abundance	is	observed	upon	mitotic	entry,	as	measured	by	nuclear	620	 translocation	Cyclin	B1.	From	these	data,	we	conclude	that	RRM2	levels	decrease	during	621	 early	mitosis	in	both	NB4	and	U2OS	cells.		622	 We	next	explored	potential	mechanisms	leading	to	targeted	degradation	of	623	 RRM2.	Like	CycA,	the	prometaphase	decrease	in	RRM2	levels	occurs	in	the	presence	of	624	 an	active	spindle	assembly	checkpoint	(SAC)	(Fig.	9E).	Mitotic	degradation	of	RRM2	is	625	 sensitive	to	4	hrs	of	MG-132	treatment,	suggesting	that	the	degradation	occurs	via	the	626	 proteasome	pathway.	Inhibition	of	APC/C	activity,	using	combined	treatment	with	apcin	627	 and	proTAME	(Sackton	et	al.	2014),	was	sufficient	to	block	CycB	degradation,	but	628	 insufficient	to	stop	CycA	and	RRM2	degradation	in	NB4	cells.	In	contrast,	treatment	with	629	 MLN-4924	(Soucy	et	al.	2009),	an	inhibitor	of	NEDDylation	and	cullin	ring	ligases	630	 (CRLs),	completely	blocks	the	decrease	of	RRM2	levels	in	prometaphase	and	leads	to	631	 levels	either	similar,	or	even	slightly	higher,	than	observed	in	control	cells	(Fig.	9F).	As	632	
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expected,	the	decrease	in	CycA	in	prometaphase	is	largely	unaffected	in	MLN-4924	633	 treated	cells	(data	not	shown).	634	 We	conclude	that	RRM2	is	targeted	for	proteasomal	degradation	during	early	635	 mitosis	via	a	MLN-4924-sensitive	pathway,	probably	involving	an	SCF	complex.	As	636	 discussed	further	below,	a	likely	candidate	is	the	cyclin	F/SCF	complex,	as	RRM2	has	637	 been	described	previously	as	a	substrate	of	this	E3	ligase	(D'Angiolella	et	al.	2012).	638	 	To	maximize	community	access	to	the	entire	dataset	described	in	this	study,	639	 including	the	measurements	of	protein	accumulation	across	the	cell	cycle,	the	640	 proteomics	data	are	freely	available	via	several	outlets,	including	the	Encyclopedia	of	641	 Proteome	Dynamics	(http://www.peptracker.com/epd/)	(Brenes	et	al.	2017)	(Fig.	10).		642	 The	EPD	provides	a	searchable,	open	access	database	containing	also	proteome	643	 measurements	from	multiple	large-scale	experiments	on	human	cells	and	model	644	 organisms	(Larance	et	al.	2013).	The	data	are	also	available	at	various	stages	of	analysis,	645	 including	raw	MS	files	and	MaxQuant-generated	output	(ProteomeXchange)	and	646	 analysed	data	(Supplementary	Files).	647	
Discussion	648	 A	major	challenge	with	the	biochemical	analysis	of	mitotic	cells	is	that	each	sub-649	 phase	of	mitosis	is	exceedingly	short,	lasting	only	minutes	(Sullivan	&	Morgan	2007).	650	 Additionally,	there	is	significant	cellular	heterogeneity	in	phase	dwell	times.	Timing	651	 heterogeneity,	which	can	be	accounted	for	in	timelapse	imaging	studies	(Akopyan	et	al.	652	 2014),	present	major	technical	challenges	to	synchronization-based	strategies	for	653	 biochemical	analysis.	In	this	study,	we	characterize	the	PRIMMUS	method,	which	654	 provides	a	flexible	approach	that	facilitates	quantitative	proteomic	studies	on	specific	655	 cell	subsets	isolated	by	FACS	based	on	staining	for	intracellular	antigens.		For	656	 separation	of	interphase	cells	(G1,	S,	G2),	centrifugal	elutriation	is	an	alternative	to	657	
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FACS,	but	provides	lower	resolution	separation,	is	not	applicable	to	all	cell	types	and	658	 does	not	efficiently	separate	G2	and	M	phase	cells.	We	therefore	used	FACS	to	produce	659	 highly	enriched	populations	of	cells	at	specific	cell	cycle	stages.	Cells	growing	in	660	 asynchronous	cultures	were	FACS	separated	by	either,	a)	DNA	content	and	661	 phosphorylation	of	histone	H3,	obtaining	high	purity	populations	of	G1,	S,	G2	and	M	662	 phase	cells,	or	by	b)	DNA	content,	phosphorylation	of	histone	H3	and	the	degradation	of	663	 CycA,	obtaining	high	purity	populations	of	prophase,	prometaphase	and	anaphase	intra-664	 mitotic	cells.	Using	these	isolated	cell	populations,	we	provide	the	first	specific	MS-665	 based	proteomic	analysis	of	intra-mitotic	phase	cells	isolated	from	asynchronously	666	 growing	cultures.	667	 We	validated	the	PRIMMUS	method	by	demonstrating	that	global	MS-based	668	 protein	identification	and	quantitation	is	compatible	with	the	analysis	of	populations	of	669	 fixed	cells	that	have	been	permeabilised,	stained	to	detect	intracellular	antigens	and	670	 isolated	by	FACS.	While	FACS	has	been	used	previously	in	conjunction	with	RNA-seq	to	671	 compare	mRNA	abundances	of	cell	subsets	(Hrvatin	et	al.	2014),	this	study	provides	the	672	 first	example	we	know	of	where	permeabilised,	fixed	and	intracellular	immunostained	673	 cells	have	been	FACS	sorted	and	used	for	quantitative,	MS-based	proteome	analysis.	In	674	 principle,	the	PRIMMUS	approach	can	be	used	to	characterize	any	distinct	type	of	cell	675	 subpopulation	that	can	be	defined	using	one	or	more	diagnostic	antigens,	an	abundance	676	 differential	for	a	specific	epitope,	or	combination	of	epitopes,	including	intracellular	and	677	 intranuclear	antigens.		We	also	show	that	PRIMMUS	enhances	the	sensitivity	of	678	 quantitative	proteomics	technology	to	detect	either	changes	in	abundance,	and/or	679	 changes	in	other	protein	properties,	such	as	post-translational	modifications,	because	it	680	 facilitates	the	analysis	of	the	specific	subsets	of	cells	in	which	the	change	occurs,	681	 without	diluting	this	signal	by	analyzing	mixed	populations,	including	non-responding	682	
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cells.	This	is	illustrated	here	by	our	demonstration	of	up	to	a	five-fold	sensitivity	gain	in	683	 detecting	cell	cycle	regulated	protein	abundance	changes,	as	judged	by	comparing	data	684	 obtained	using	PRIMMUS,		with	data	from	cells	isolated	using	centrifugal	elutriation.		685	 We	have	recently	shown	by	proteomic	analysis	of	NB4	cells	arrested	at	specific	686	 cell	cycle	stages	by	drug	treatments	that	the	stress	resulting	from	drug	arrest	causes	687	 major	changes	in	the	proteome	distinct	from	the	physiological	regulation	of	protein	688	 levels	during	unperturbed	cell	cycle	progression	(Ly	et	al.	2015).	In	the	PRIMMUS	689	 method,	fixation	by	FA	captures	cells	‘frozen	in	motion’	and	thereby	prevents	significant	690	 perturbation	of	cellular	physiology	due	to	extended	sample	handling.	Consistent	with	691	 this	idea,	we	previously	showed	that	that	the	abundance	of	the	apoptosis-associated	692	 protein	BID	is	upregulated	by	the	CDK1	inhibitor	RO-3306,	which	arrests	cells	at	the	G2	693	 and	M	border	(Ly	et	al.	2015).	In	this	study,	using	PRIMMUS,	we	observe	BID	levels	stay	694	 relatively	constant	across	the	unperturbed	cell	cycle,	consistent	with	our	results	695	 comparing	minimally	perturbed	cells	separated	by	centrifugal	elutriation	(Ly	et	al.	696	 2014).	While	FACS	can	also	be	used	to	sort	live	cells,	thereby	avoiding	procedures	697	 involving	fixation	and	permeabilisation,	the	process	of	FACS-based	separation	of	live	698	 cells	can	induce	cellular	stress	and	this	in	turn	can	rapidly	alter	the	proteome.	The	699	 proteomes	of	live	cells	immediately	after	FACS	may	thus	be	significantly	remodeled	by	700	 activation	of	cellular	stress	responses.	Furthermore,	most	live	cell	strategies	require	the	701	 construction	of	transformed	cell	lines	expressing	one	or	more	fluorescent-tagged	fusion	702	 proteins.	In	contrast,	the	PRIMMUS	approach	described	here	avoids	any	requirement	703	 for	the	use	of	exogenous,	tagged	proteins	and	provides	a	general	strategy	that	can	be	704	 applied	to	both	cultured	cell	lines	and	primary	cells	isolated	ex	vivo.	705	 We	used	PRIMMUS,	combined	with	high	accuracy	cell	mixing	and	quantitative	706	 metabolic	labeling,	to	measure	and	compare	the	abundances	of	thousands	of	individual	707	
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proteins	across	an	unperturbed	cell	division	cycle,	including	different	substages	of	708	 mitosis.	Our	data	show	that	while	exponential	accumulation	is	observed	for	bulk	709	 protein,	the	rate	of	accumulation	of	individual	proteins	can	deviate	significantly	from	an	710	 exponential	growth	fit.	For	example,	histones,	which	constitute	~3-5%	of	the	total	711	 protein	abundance	in	NB4	cells	(Ly	et	al.	2014),	deviate	from	bulk	protein	accumulation	712	 by	remaining	flat	between	G2	and	M,	consistent	with	the	synchronization	of	DNA	713	 replication	and	histone	synthesis	(Nelson	et	al.	2002),(Robbins	&	Borun	1967).	714	 Intriguingly,	for	p53	and	some	other	proteins	associated	with	stress	responses	and/or	715	 apoptosis,	protein	abundance	remains	relatively	flat	across	the	cell	division	cycle.	Due	716	 to	cell	cycle-dependent	increases	in	cell	size	and	bulk	protein	abundance,	the	effective	717	 net	intracellular	concentrations	of	these	proteins	must	thus	decrease	as	the	cell	cycle	718	 progresses.	Any	functional	consequence	of	a	decrease	in	their	abundance	may	however	719	 be	offset	if	mechanisms	exist	to	create	local	concentration	hotspots	at	specific	720	 subcellular	locations.		721	 Detailed	proteomic	analysis	of	protein	abundances	across	prophase,	722	 prometaphase	and	anaphase	cells	showed	that	only	~1.5%	of	the	proteins	quantitated	723	 significantly	decrease	in	abundance.	These	proteomic	data	showed	RRM2	levels	724	 decreasing	during	prometaphase.	Consistent	with	this,	subsequent	flow	cytometry	725	 analysis	showed	that	RRM2	and	CycA	levels	are	correlated	during	mitosis.	In	U2OS	cells,	726	 RRM2	levels	degrade	in	early	mitosis,	either	coincident	with,	or	sometime	shortly	after	727	 the	appearance	of	cyclin	B1	in	the	nucleus.		728	 The	decrease	in	RRM2	levels	was	prevented	by	treatment	of	cells	with	either	729	 MLN-4924,	or	MG-132,	consistent	with	the	mechanism	causing	a	decrease	in	RRM2	730	 levels	involving	a	cullin	E3	ubiquitin	ligase	and	proteasomal	degradation.	It	has	been	731	 shown	that	RRM2	is	targeted	for	degradation	by	Cyclin	F/SCF	during	G2	(D'Angiolella	et	732	
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al.	2012)	and	several	studies	have	shown	co-immunoprecipitation	of	RRM2	and	Cyclin	F	733	 in	asynchronous	cell	extracts	(D'Angiolella	et	al.	2012;	Huttlin	et	al.	n.d.;	Hein	et	al.	734	 2015).	It	has	also	been	reported	that	disruption	of	the	Cy	motif	in	RRM2,	which	is	735	 important	for	recognition	by	Cyclin	F/SCF,	stabilizes	RRM2	levels	and	increases	DNA	736	 pools	and	genome	mutation	frequencies	(D'Angiolella	et	al.	2012).	It	will	be	interesting	737	 in	the	future	to	investigate	further	the	timing	of	RRM2	degradation	and	its	relation	to	738	 maintaining	genome	stability.		739	 We	show	that	PRIMMUS	is	compatible	also	with	analysis	of	cell	cycle	regulated	740	 protein	phosphorylation	by	comparing	phosphorylation	in	G1-,	S-,	G2-	and	M-phase	741	 enriched	fractions	purified	by	FACS.	While	essentially	all	significantly	changing	742	 phosphorylation	sites	peak	during	mitosis,	we	identify	a	subset	of	phosphorylation	sites	743	 that	show	increased	phosphorylation	in	the	G2-enriched	fraction,	which	we	call	‘early	744	 risers’.	These	early	risers	share	functional	similarities,	including	enrichment	in	the	745	 ‘classic’	CDK	substrate	phosphorylation	motif	and	localization	to	chromatin	and	the	746	 nuclear	envelope.	We	suggest	that	these	early	rising	sites	may	be	the	downstream	effect	747	 of	mitotic	entry	kinase	activity,	which	includes	contributions	from	Plk1	(Smith	et	al.	748	 2011),	Cdk1(Gavet	&	Pines	2010),	and	Cyclin	A-CDK2	(Gong	et	al.	2007).		Interestingly,	749	 the	sites	that	change	by	the	highest	amount	in	G2,	besides	factors	strongly	associated	750	 with	DNA	replication,	are	localized	to	the	nuclear	pore	and	nuclear	envelope.		751	 Additionally,	several	sites,	such	as	on	lamina-associated	polypeptide	2	(LAP2)	and	752	 NUP153,	contain	both	Plk1	and	Cdk	substrate	sequence	motifs	(Supplementary	File	2).	753	 Proteins	at	the	nuclear	envelope,	including	lamin	B	and	NUP153,	have	been	shown	to	be	754	 likely	candidate	substrates	for	Cyclin	A/CDK2	(Chi	et	al.	2008).	Evidence	from	755	 immunoprecipitation	experiments	suggest	that	these	proteins	may	not	be	exclusively	756	 Cyclin	A/CDK2	targets,	as	there	is	significant	overlap	in	proteins	immunoprecipitated	757	
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with	Cyclin	A	vs.	Cyclin	B	(Pagliuca	et	al.	2011).	That	‘early	rising’	phosphorylations	758	 show	significant	increase	in	the	mitotic	fraction	is	consistent	with	increasing	CDK	759	 activity	for	the	same	substrates	in	the	transition	from	from	cyclin	A/CDK2	to	cyclin	760	 B/CDK1	(Uhlmann	et	al.	2011)	(Stern	&	Nurse	1996).	An	expanded	analysis	of	761	 phosphorylation	during	S-	and	G2-phases	will	be	an	important	goal	of	future	studies	762	 and	will	help	to	define	the	targets	of	the	mitotic	entry	network	in	detail.	This	may	763	 provide	clues	to	the	sequence	of	signaling	events	that	precede	nuclear	envelope	764	 breakdown.	Future	studies	will	also	explore	phosphorylation	changes	between	mitotic	765	 subphases,	which	will	help	elucidate	the	role	of	mitotic	kinases	and	phosphatases	766	 during	progression	through	mitosis.	767	 When	the	phosphoproteomic	dataset	from	this	study	was	compared	with	a	768	 previously	reported	atlas	of	mitotic	phosphorylation	in	human	cells	derived	using	769	 nocodazole	arrested	HeLa	cells	(Olsen	et	al.	2010),	some	phosphorylation	sites	were	770	 identified	that	changed	in	one	dataset,	but	not	the	other.	The	sites	that	differed	between	771	 the	two	datasets	were	preferentially	on	proteins	with	specific	functional	GO	772	 annotations,	including	‘cell	cycle’	and	‘mitosis’	for	phosphorylation	sites	that	are	773	 changing	exclusively	in	the	mitotic	fraction	in	this	PRIMMUS	dataset,	but	instead	774	 proteins	with	phosphorylation	sites	that	are	changing	exclusively	in	the	mitotic	fraction	775	 in	the	previously	reported	HeLa	dataset	are	enriched	for	the	annotation	‘splicing’	and	776	 not	‘cell	cycle’	or	‘mitosis’.	Several	differences	between	these	studies	could	explain	777	 study-specific	phosphorylation	changes.	For	example,	cell-type	specificity	in	cell	cycle	778	 regulated	protein	phosphorylation,	e.g.	NB4	cells	(this	study),	as	compared	with	HeLa	779	 cells	used	in	the	previous	study.	An	alternative,	non-mutually	exclusive,	explanation	780	 could	be	the	difference	in	the	methods	used	for	obtaining	mitotic	cells	in	the	respective	781	 studies,	i.e.	FACS	(this	study)	vs	nocodazole-arrest	(HeLa	dataset	(Olsen	et	al.	2010)).	782	
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Previous	work	has	shown	that	cell	cycle	arrests	can	induce	proteomic	changes	that	are	783	 not	observed	in	a	minimally	perturbed	cell	cycle	(Ly	et	al.	2015).	Further	analysis	will	784	 be	required	to	investigate	the	basis	for	the	observed	study-specific	phosphorylation	785	 changes.	786	 We	show	that	for	the	TPX2	protein,	the	phosphorylation	increase	observed	787	 during	G2	and	mitosis	has	functional	consequences	on	spindle	formation.	Specifically,	788	 mutation	of	the	early	rising	phosphorylation	site,	TPX	S738,	to	either	a	non-789	 phosphorylatable	(alanine)	or	a	phosphomimetic	(aspartic	acid)	residue,	elicits	defects	790	 in	bipolar	spindle	assembly.	The	738	residue	lies	within	a	critical	C-terminal	domain	of	791	 TPX2	that	has	been	shown	to	be	important	both	in	recruiting	the	mitotic	kinesin	Eg5	to	792	 spindle	microtubules	in	cells	and	in	modulating	Eg5-dependent	microtubule	gliding	793	 activity	in	vitro	(Ma	et	al.	2011;	Eckerdt	et	al.	n.d.).	The	phenotypes	of	the	794	 phosphomimetic	and	non-phosphorylatable	mutations	at	S738	in	TPX2	are	not	as	795	 severe	as	loss	of	the	entire	C-terminal	domain	(Ma	et	al.	2011)		suggesting	that	796	 phosphorylation	at	this	site	modulates,	but	does	not	abolish,	the	interaction	with	Eg5.		A	797	 variety	of	defects	were	observed	for	each	mutant,	including	monopolar	and	multipolar	798	 spindles,	suggesting	defects	in	motor	dependent	force	generation	during	spindle	799	 formation.		800	 Prior	work	has	shown	that	Eg5	is	transported	poleward	in	a	dynein-dependent	801	 manner	during	early	mitosis	and	reverses	direction	in	anaphase,	moving	away	from	the	802	 spindle	poles	(Gable	et	al.	2012;	Uteng	et	al.	2008).		However,	in	cells	depleted	of	TPX2,	803	 Eg5	moves	away	from	the	poles,	toward	microtubule	plus-ends	in	early	mitosis,	804	 showing	that	TPX2	is	needed	to	couple	Eg5	to	dynein.		Thus,	the	dynamics	of	Eg5	805	 change	in	a	TPX2	and	cell	cycle	regulated	manner,	consistent	with	a	regulated	806	 interaction	between	the	two	proteins.	Because	the	TPX2-738	phosphorylation	site	was	807	
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classified	as	an	early	riser,	an	early	mitotic	phenotype	might	be	expected.		TPX2	808	 contains	a	functional	NLS	and	is	nuclear	throughout	interphase;	a	small	fraction	of	the	809	 protein	has	been	detected	at	the	centrosome,	in	prophase,	in	mammalian	cells	(Ma	et	al.	810	 2011;	Vos	et	al.	2008).	Evidence	in	plant	cells	suggest	a	role	during	early	prophase	(Vos	811	 et	al.	2008).	In	these	cells,	TPX2	is	detected	on	microtubules	outside	of	the	prophase	812	 nucleus	and	microinjection	of	anti-TPX2	antibodies	during	prophase	inhibits	nuclear	813	 envelope	breakdown.	In	mammalian	cells,	the	weak	signal	from	cytoplasmic	TPX2-GFP	814	 at	prophase	and	the	small	number	of	prophase	cells	precluded	detecting	any	possible	815	 phenotype	in	the	present	experiments.	It	should	be	noted	that	other	work	has	identified	816	 nuclear	roles	for	TPX2	in	the	DNA	damage	response	(Neumayer	et	al.	2014)	so	it	817	 remains	possible	that	phosphorylation	of	TPX2	regulates	multiple	events	throughout	818	 the	cell	cycle.				819	 In	addition	to	PTM	analyses,	the	PRIMMUS	workflow	can	be	extended	in	future	820	 by	combining	it	with	other	complementary	approaches	to	extend	the	depth	of	821	 proteomic	analysis	of	the	selected	cell	subpopulations	beyond	only	abundance	822	 measurements,	e.g.	using	MS-based	techniques	for	identifying	protein	interaction	823	 partners	and	protein	complexes	(Kirkwood	et	al.	2013),(Kristensen	et	al.	2012).	824	 PRIMMUS	is	highly	complementary	to	recent	studies	dissecting,	in	high	resolution,	the	825	 timing	of	mitotic	kinase	activities	and	quiescence	control	by	automated	fluorescence	826	 imaging	of	fixed,	immunostained	cells	(Akopyan	et	al.	2014;	Spencer	et	al.	2013).	As	FA	827	 fixed	cells	are	compatible	with	downstream	RNA-seq	analysis	and	ChIP	studies,	828	 combining	proteomics	on	sorted	cells	also	with	these	high-throughput	approaches	829	 would	expand	the	in-depth	analysis	of	gene	expression	(transcriptome	and	proteome)	830	 of	rare	populations	and/or	biochemically	well-defined	subpopulations,	such	as	specific	831	
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hematopoeitic	cell	populations	that	cannot	be	separated	on	the	basis	of	cell	surface	832	 markers	alone.	833	
Materials	and	methods	834	
Key	resources	table	835	
Reagent type 
(species) or 
resource 
Designation Source or reference Identifiers Additional information 
Human Cell Line NB4 Ron Hay lab (Dundee), Lanotte 1991 CVCL_0005 
Tested negative for mycoplasma 
(Lonza MycoAlert) 
Human Cell Line HeLa ATCC CVCL_0030 Tested negative for mycoplasma 
Human Cell Line U2OS ATCC CVCL_0042 Tested negative for mycoplasma 
Porcine Cell Line LLC-Pk1 ATCC CVCL_0391 Tested negative for mycoplasma 
Antibody rat anti-tubulin YL1/2 Accurate Scientific AB_2687885   
Antibody rabbit anti-RRM2 Human Protein Atlas AB_2683304   
Antibody mouse anti-H3S10ph 
Cell Signaling 
Technology AB_331749   
Antibody rat anti-H3S28ph HTA28 Abcam AB_2295065   
Antibody mouse anti-tubulin (DM1a) Sigma AB_477593   
DNA, Expression 
construct RRM2-GFP Origene RG205718   
	836	
Cell	culture	837	 The	NB4	cell	line	(RRID:	CVCL_0005)	was	originally	established	from	acute	838	 myeloid	leukemia	blast	cells	grown	on	bone-marrow	stromal	fibroblasts	(Lanotte	et	al.	839	 1991).	NB4	cells	were	obtained	from	the	Hay	laboratory	(University	of	Dundee).	Cells	840	 were	cultured	at	37	°C	in	the	presence	of	5%	CO2	as	a	suspension	in	RPMI-1640	(Life	841	 Technologies)	supplemented	with	2	mM	L-glutamine,	10%	v/v	foetal	bovine	serum	842	 (FBS,	Life	Technologies),	100	units/ml	penicillin	and	100	μg/ml	streptomycin	(100X	843	 stock,	Life	Technologies).	Cell	cultures	were	maintained	at	densities	between	1	x	105	to	844	 1	x	106	cells/ml.	For	SILAC	labeling,	culture	media	without	arginine	or	lysine	(DCP)	was	845	 supplemented	with	either	‘light’	(Arg0,	Lys0,	Cambridge	Isotope	Labs)	or	‘heavy’	846	
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(Arg10,	Lys8,	Cambridge	Isotope	Labs)	isotopomers	of	arginine	and	lysine.	SILAC	847	 labeling	media	was	additionally	supplemented	with	dialysed	serum	(10%	final),	1X	848	 insulin-transferrin-selenium	(100X	stock	from	Life	Technologies),	1x	MEM	vitamins	849	 (100X	stock	from	Life	Technologies),	and	90	mg/L	proline.	The	U2OS	cell	line	(U2OS;	850	 RRID:	CVCL_0042)	was	cultivated	at	37oC	in	a	5%CO2	humidified	environmental	851	 condition	using	McCoy’s	5A	modified	medium	supplemented	with	10%	fetal	bovine	852	 serum	(FBS,	Sigma)	and	1%	L-glutamine.	Cells	were	harvested	at	around	60%	853	 confluency	using	trypsin	(Trypsin-EDTA	solution	from	Sigma-Aldrich).	HeLa	cells	854	 (ATCC,	RRID:	CVCL_0030)	were	cultured	in	DMEM	media	supplemented	with	10%	FBS	855	 (Gibco,	South	American	origin)	and	penicillin/streptomycin.	For	transfection	856	 experiments,	lipid	complexes	were	prepared	in	serum-free	media	(Opti-MEM,	Gibco)	857	
TPX2	depletion	and	rescue	experiments	858	 LLC-Pk1	cells	(CVCL_0391)	were	grown	in	Hams	F-10	mixed	one	to	one	with	859	 Opti-MEM,	and	containing	7.5%	fetal	calf	serum	and	antibiotic/antimycotic	at	37	C	and	860	 5%	CO2.		Prior	to	use	in	experiments	cells	were	plated	on	22	X	22	mm	#1.5	coverslips	in	861	 35	mm	dishes	or	on	to	the	surface	of	glass	bottom	petri	dishes	(Mattek	Corp).			862	 To	generate	mutants	at	residue	S738,	a	mouse	bacterial	artificial	chromosome	863	 (BAC)	expressing	a	localization	and	affinity	purification	tagged	TPX2	was	used	(referred	864	 to	hereafter	as	GFP	tagged).		Mutations	were	generated	using	site	directed	mutagenesis	865	 in	bacteria	and	confirmed	by	sequencing	(Poser	et	al.	2008).	Purified	BAC	DNA	was	866	 nucleofected	into	LLC-Pk1	cells	using	an	Amaxa	nucleofector	and	Mirus	nucleofection	867	 reagent	and	antibiotic	selection	was	performed	as	previously	described	(Ma	et	al.	868	 2011).	Prior	to	use	in	experiments,	the	cells	were	nucleofected	with	siRNA	targeting	869	 endogenous	pig	TPX2	(5’	GAAUGGUACAGGAGGGCUU	3’).		To	score	mitotic	morphology,	870	 live	cells	were	imaged	on	a	confocal	microscope	in	the	GFP	channel	or	following	fixation	871	
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(3.7%	paraformaldehyde,	0.1%	glutaraldehyde	in	PBS	containing	0.5%	Triton	X-100)	872	 and	staining	for	microtubules	using	a	mouse	anti-tubulin	antibody	(DM1a,	RRID:	873	 AB_477593)	or	rat	anti-tubulin	(YL1/2,	RRID:	AB_2687885)	and	appropriate	secondary	874	 antibodies.		Incubations	with	primary	antibodies	were	performed	for	either	1	hour	at	875	 37	C	or	overnight	at	room	temperature;	secondary	antibodies	were	used	at	room	876	 temperature	for	45	min.		Antibodies	were	mixed	at	the	appropriate	final	dilution	with	877	 PBS	containing	2%	BSA,	0.1%	Tween	and	0.02%	sodium	azide.		Cells	were	imaged	using	878	 a	Nikon	Eclipse	TE300	or	TiE	equipped	with	a	Yokagawa	spinning	disc	scan	head	and	879	 100X		NA	1.4	objective	lens		as	previously	described	(Ma	et	al.	2011).	Image	analysis	880	 was	performed	in	ImageJ	or	FIJI.		For	long-term	imaging,	cells	were	imaged	on	a	Nikon	881	 TiE	with	a	spinning	disc	confocal	system	(Yokogawa)	at	40X.		Cells	were	maintained	at	882	 37	C	and	5%	CO2	using	an	Oko	Lab	environmental	stage	insert.			Images	were	collected	883	 from	multiple	points	at	3	min	intervals;	images	were	collected	at	488nm	or	both	the	488	884	 and	561nm	for	3-5	hours.		To	measure	mitotic	duration,	the	time	between	nuclear	885	 envelope	breakdown	and	anaphase	was	measured	from	the	488	channel.	886	
Immunofluorescence	staining	887	 NB4	cells	(~0.5	x	108	cells)	were	washed	once	with	phosphate-buffered	saline	888	 (PBS)	and	resuspended	in	freshly	prepared	50	ml	0.5%	formaldehyde	in	PBS.	Cells	were	889	 fixed	with	formaldehyde	for	30	min	at	room	temperature	with	shaking.	Cells	were	890	 pelleted,	and	permeabilised	with	50	ml	cold	90%	methanol.	Cells	were	then	stored	at	-891	 20°C	prior	to	staining.	892	 Fixed,	permeabalised	cells	were	washed	once	with	PBS	and	resuspended	in	893	 blocking	buffer,	5%	bovine	serum	albumin	(BSA)	in	Tris-buffered	saline	(TBS)	+	0.05%	894	 sodium	azide.		Cells	were	blocked	for	10	min	at	room	temperature,	pelleted,	and	895	 resuspended	in	primary	antibody	solution	(1:200	in	blocking	buffer).	Cells	were	stained	896	
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with	primary	antibody	overnight	at	4°C.	The	primary	antibodies	used	for	897	 immunostaining	are	rabbit	anti-RRM2	(HPA056994,	RRID:	AB_2683304),	mouse	anti-898	 H3S10ph	(Cell	Signaling	Technology	9706,	RRID:	AB_331749),	rat	anti-H3S28ph	HTA28	899	 (Abcam	ab10543,	RRID:	RRID:	AB_2295065),	and	mouse	anti-alpha	tubulin	(Sigma	900	 DM1a,	RRID:	AB_477593).		Stained	cells	were	then	washed	twice	with	PBS,	and	stained	901	 with	dye-conjugated	secondary	antibodies	(1:200	in	blocking	buffer)	for	1	hour	at	room	902	 temperature.	Stained	cells	were	washed	twice	with	PBS,	pelleted,	and	resuspended	in	903	 DAPI	solution	(5	µg/ml	in	PBS).		904	 Immunostaining	of	the	human	U2OS	cells	was	performed	in	a	glass	bottom	plate	905	 (Greiner	Sensoplate	Plus,	Cat#	655892,	Greiner	Bio-One,	Germany) coated	with	12.5-906	 μg/ml	human	fibronectin	(VWR).	Approximately	6,000	cells	were	seeded	in	each	well	907	 and	incubated	at	37	°C	for	24	hours.	After	washing	with	Phosphate	buffered	saline	908	 (PBS),	cells	were	fixed	with	40	μl	4%	ice	cold	PFA	(Sigma	Aldrich)	dissolved	in	growth	909	 medium	supplemented	with	10	%	serum	for	15	minutes	and	permeabilized	with	40	μl	910	 0.1%	Triton	x-100	(Sigma	Aldrich)	in	PBS	for	3x5	minutes.	The	primary	antibody	911	 targeting	RRM2	(HPA056994,	RRID:	AB_2683304),	was	dissolved	to	2	μg/ml	in	blocking	912	 buffer	(PBS	+	4%	FBS)	containing	1μg/ml	chicken	anti-tubulin	(Abcam,	ab89984,	RRID:	913	 AB_10672056)	and	2.5	μg	/ml	mouse	anti-CCNB1	(BD	Biosciences	610220,	RRID:	914	 AB_397617).		After	washing	the	cells	with	PBS,	diluted	primary	antibodies	were	added	915	 (40	μl/well)	and	the	plates	were	incubated	at	4	°C.	After	overnight	incubation,	all	wells	916	 were	washed	with	PBS	for	3x10	minutes.	Secondary	antibodies,	goat	anti-rabbit488	917	 (ThermoFisher	A11034,	RRID:	AB_2576217),	goat	anti-mouse555(ThermoFisher	918	 A21424,	RRID:	AB_141780)	and	goat	anti-chicken647	(ThermoFisher	A21449,	919	 RRID:AB_2535866)	diluted	to	2.5	μg	/ml	in	blocking	buffer	were	added	and	the	plates	920	
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incubated	for	90	minutes	at	room	temperature.	After	washing	with	PBS,	all	wells	were	921	 mounted	with	PBS	containing	76.5%	glycerol.	922	 RRM2	depletion	and	overexpression	923	 	 HeLa	cells	were	transfected	with	either	siJumble	(Hutten	et	al.	2014),	or	a	pool	of	924	 4	siRNA	targeting	RRM2	(ON-TARGETplus	siRNA,	GE	Healthcare	L-010379-00)	using	925	 Lipofectamine	RNAiMAX	(ThermoFisher	Scientific)	using	manufacturer’s	instructions.	926	 Cells	were	incubated	24	hr	before	harvest	for	immunoblot	and	flow	cytometry	assays.	927	 For	overexpression	experiments,	HeLa	cells	were	transfected	with	either	GFP-fibrillarin,	928	 or	RRM2-GFP	(Origene	RG205718)	using	Lipofectamine	3000	(ThermoFisher	929	 Scientific).	Transfected	cells	were	incubated	for	24	hr	before	harvesting	for	930	 immunostaining	using	mouse	anti-GFP	(Roche,	RRID:	AB_390913)	and	rabbit	anti-931	 RRM2	primary	antibodies	(HPA056994,	RRID:	AB_2683304).		932	
Flow	cytometric	analysis	of	cell	cycle	distribution	933	 Cells	stained	with	either	PI	or	DAPI	were	analysed	on	an	LSR	Fortessa	flow	934	 cytometer	and	data	acquired	using	DIVA	software	(Becton	Dickinson).	DNA	content	was	935	 evaluated	based	on	DAPI	fluorescence	(measured	using	355nm	excitation	and	emission	936	 at	450±50nm)	or	PI	fluorescence	(measured	using	488nm	excitation	and	emission	at	937	 585±42nm).	Doublet	discrimination	was	used	to	remove	cell	doublets	and	clumps	using		938	 DAPI/PI-A	and	DAPI/PI-W	measurements.	The	cell	cycle	distribution	of	single	(gated)	939	 cells	was	plotted	as	DAPI/PI-A.	Data	was	analysed	using	Flowjo	software	(Treestar	inc.)	940	 and	cell	cycle	distributions	determined	using	the	Watson/Pragmatic	model.	941	
Fluorescence	Activated	Cell	Sorting	(FACS)		942	 FACS	was	performed	on	an	Influx	cell	sorter	(Becton	Dickinson)	equipped	with	943	 488nm,	405nm,	and	642nm	laser	light	sources.	Forward	angle	light	scatter	(FSC)	and	944	 side	angle	(90°)	light	scatter	(SSC)	were	determined	by	detection	of	scattered	488nm	945	
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light.	DAPI	fluorescence	was	measured	using	405nm	excitation	and	emission	detected	946	 at	460±50nm,	Alexa	Fluor	488	fluorescence	was	measured	using	488nm	excitation	and	947	 emission	detected	at	530±40nm,	Alexa	Fluor	568	fluorescence	was	measured	using	948	 488nm	excitation	and	emission	detected	at	610±20nm,	and	Alexa	Fluor	647	949	 fluorescence	was	measured	using	642nm	excitation	and	emission	detected	at	950	 670±30nm.	951	 Signal	processing	was	performed	by	a	16-bit	analogue	to	digital	converter,	952	 providing	65,536	channels.	Linear	scaling	(0	to	65,536	channels)	or	logarithmic	scaling	953	 (four	log	decades	of	16,384	channels)	of	data	was	performed,	depending	on	parameter	954	 detected	(see	below).	All	parameters	are	presented	as	measurements	of	pulse	height,	955	 unless	otherwise	stated.	Compensation	was	not	applied	due	to	the	careful	selection	of	956	 spectrally	distinct	fluorophores,	minimizing	spectral	overlap,	and	gating	strategies	957	 employed.	958	 For	cell	sorting	phosphate	buffered	saline	pH	7.5	(PBS,	Sigma	Cat	no.	P-4417)	959	 was	used	as	sheath,	and	sorting	was	performed	using	a	100	μm	nozzle	and	sheath	960	 pressure	of	20	psi.	Typical	drop	drive	frequency	used	was	in	the	region	of	40	kHz,	961	 enabling	a	maximum	event	rate	for	sorting	of	10,000	events	per	second	(i.e.	1	event	per	962	 four	drops).	The	sorting	mode	selected	was	drop	count=1.0,	drop	attributes=	pure	(this	963	 ensures	exact	counts	of	cells	collected	and	sort	purity).	964	 Immediately	prior	to	sorting,	cells	were	passed	through	a	50	μm	filter	(Filcons,	965	 Becton	Dickinson	Cat	no.	340629)	to	remove	cell	clumps.	Sorted	cells	were	collected	966	 into	either	1.5	ml	or	2.0	ml	Protein	LoBind	Eppendorf	tubes	containing	~50	µl	of	PBS.	967	 Where	cell	numbers	allowed,	post-sort	purity	was	checked	by	reanalysis	of	the	collected	968	 cells	by	flow	cytometry,	and	found	to	be	>96%	in	all	cases.	Sorting	and	data	analysis	969	
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during	sorting	was	performed	using	FACS	Sortware	(Becton	Dickinson)	and	post-sort	970	 data	analysis	performed	using	Flowjo.	971	
FACS	population	identification	and	gating	strategies	972	 To	separate	interphase	and	mitotic	cells,	cells	were	distinguished	from	973	 particulate	material	based	on	FSC	and	SSC	(Suppl.	Fig.	1A).	DAPI	fluorescence	was	974	 detected	and	presented	on	a	linear	scale,	setting	the	G1	peak	at	approximately	channel	975	 20,000	to	allow	good	resolution	of	cell	cycle,	while	keeping	all	data	on	scale.	Integration	976	 of	the	DAPI	signal	pulses	was	performed	electronically	to	provide	pulse	area	(A)	and	977	 pulse	width	(W),	as	well	as	pulse	height	(H).	Cell	doublets	and	aggregates	were	excluded	978	 based	on	DAPI-W	v	DAPI-A	measurements.	G1,	S	and	G2	phases	of	the	cell	cycle	were	979	 identified	based	on	DNA	content,	determined	from	histogram	plots	of	DAPI-A.	In	order	980	 to	minimize	contamination	of	samples	with	other	phases	of	the	cell	cycle,	the	bottom	981	 half	of	the	G1	peak,	top	half	of	the	G2	peak	and	middle	of	the	S	phase	were	collected	982	 (Suppl.	Fig.	1A).	H3S10ph	positive	cells	were	identified	using	either	AlexaFluor	488	983	 (H3S10ph)-conjugated	antibodies.	In	both	cases,	fluorescent	parameters	were	scaled	984	 logarithmically	and	positive	gates	for	phosphohistone	H3	determined	using	a	negative	985	 (minus	antibody)	control.	Representative	plots	of	the	gating	strategy	used	is	shown	in	986	 Suppl.	Fig.	1A.	987	 To	separate	mitotic	subphases,	interphase	and	mitotic	cells	were	first	identified	988	 based	on	DNA	content	determined	by	DAPI	staining	as	described	above.	Rat	anti-989	 H3S28ph	antibody	detected	by	anti-Rat	conjugated	AlexaFluor	568	and	Mouse	anti-990	 Cyclin	A	detected	by	anti-Mouse	conjugated	AlexaFluor647	were	employed	to	detect	the	991	 relevant	antigen,	and	logarithmic	scaling	used	for	all	two	parameters.	The	full	gating	992	 strategy	is	described	below,	where	double	carats	(>>)	indicate	the	deprecated	level	in	993	
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the	gating	hierarchy.	The	gating	strategy	is	also	shown	as	flow	diagrams	in	Suppl.	Fig.	994	 1B.	995	 [Parameters	used	for	gating:	target	subpopulations]	996	 FSC	v	SSC:	Identification	of	cells	and	elimination	of	debris	>>	DAPI-W	v	DAPI-A:	997	 Identification	of	single	4N	DNA	content	cells	and	exclusion	of	doublets	and	cell	998	 aggregates	>>	AF488-H	(pHH3)	v	AF568-H	(Cyclin	A):	Sort	gates	identifying	Cyclin	A	999	 low/H3S28ph	mid,	Cyclin	A	low/	H3S28ph	high,	Cyclin	A	high/	H3S28ph	mid,	Cyclin	A	1000	 high/	H3S28ph	high	1001	
Immunofluorescence	microscopy	1002	 Cells	purified	by	FACS	were	settled	onto	poly-lysine	coated	coverslips	(BD	1003	 Biosciences)	for	30	min	at	room	temperature.	The	liquid	was	then	carefully	aspirated.		1004	 Cells	were	fixed	with	2%	FA	in	PBS	for	10	min	at	room	temperature.	Cells	were	washed	1005	 twice	with	PBS	and	stained	with	primary	antibodies	for	1	hour	at	room	temperature.	1006	 Cells	were	washed	twice	with	PBS	and	stained	with	dye-conjugated	secondary	1007	 antibodies	for	30	min	at	room	temperature.	Cells	were	washed	twice	with	PBS	and	1008	 stained	with	DAPI	(5	µg/ml	in	PBS)	for	1	min	at	room	temperature.	Cells	were	washed	1009	 once	with	PBS	and	mounted	in	Vectashield	medium	(Vector	Laboratories).	Cells	were	1010	 visualized	using	a	wide-field	fluorescence	microscope	(Zeiss,	Jena,	Germany;	Axiovert-1011	 DeltaVision	Image	Restoration;	Applied	Precision,	LLC).		1012	 LLC-Pk1	cells	were	cultured	in	Hams	F-10	mixed	one	to	one	with	Opti-MEM,	and	1013	 containing	7.5%	fetal	calf	serum.		Prior	to	use	in	experiments	cells	were	plated	on	1014	 22X22	mm	#1.5	coverslips	in	35	mm	dishes	or	on	to	the	surface	of	glass	bottom	petri	1015	 dishes	(Mattek	Corp).		Cells	were	imaged	using	a	Nikon	A1R+	resonant	scanning	1016	 confocal	system	equipped	with	a	60X	NA	1.4	objective	lens.		For	live	cell	imaging,	cells	1017	 were	imaged	using	a	Nikon	Eclipse	TE300	or	TiE	equipped	with	a	Yokagawa	spinning	1018	
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disc	scan	head	and	100X		NA	1.4	objective	lens		as	previously	described(Ma	et	al.	2011).		1019	 Image	analysis	was	performed	in	ImageJ	or	FIJI.	1020	 U2OS	cells	were	imaged	using	a	Leica	SP5	confocal	microscope	(DM6000CS)	1021	 equipped	with	a	63-x/1.4	NA	oil	immersion	objective	was	used	for	image	acquisition.	1022	 Images	were	acquired	at	room	temperature	in	three	sequential	steps	with	the	following	1023	 scanning	settings;	Pinhole	1	Airy	unit,	16-bit	acquisition	and	a	pixel	size	of	80x80	nm.	1024	 The	z	focus-level	was	manually	adjusted	to	represent	the	best	visualization	of	the	target	1025	 protein.	The	detector	gain	was	maintained	constant	across	all	samples.	Mitotic	images	1026	 were	selected	and	the	cells	were	labeled	manually.	1027	
Cell	lysis,	reverse	crosslinking,	protein	precipitation/SP3,	Ti:IMAC	phosphoenrichment	1028	 Cells	were	resuspended	in	4%	SDS	in	PBS,	homogenised	with	a	probe	sonicator	1029	 (Branson,	10%	power,	20	sec,	4°C),	and	heated	to	95°C	for	30	min	to	reverse	crosslinks.	1030	 For	MS	analysis,	proteins	were	then	reduced	and	alkylated	using	TCEP	(25	mM	final	1031	 concentration,	Sigma)	and	iodoacetamide	(55	mM	final	concentration,	Sigma).	G1,	S,	G2,	1032	 and	M	phase	lysates	for	the	single	shot	analyses	were	then	chloroform-methanol	1033	 precipitated.		1034	 The	interphase	fractions	for	phosphoenrichment	and	the	mitotic	substage	1035	 fractions	(G2,	M,	Pro,	PM1,	PM2,	and	Ana)	were	processed	using	the	SP3	method,	as	1036	 described	previously	(Hughes	et	al.	2014).	The	mean	cell	counts	for	the	1037	 phosphoenrichment	experiment,	which	was	performed	in	biological	duplicate,	was	10,	1038	 6,	3.5,	and	1.5	million	for	G1,	S,	G2,	and	M	phase	fractions,	respectively.	The	mean	cell	1039	 counts	for	mitotic	subphases	experiment,	which	was	performed	in	biological	triplicate,	1040	 were	0.14,	0.52,	0.36,	and	0.12	million	for	Pro,	PM1,	PM2,	and	Ana	fractions,	1041	 respectively.	Lysis	buffer	volumes	were	adjusted	according	to	cell	count,	and	identical	1042	 volumes	were	used	for	TMT	labeling	and	mixing.	Cell	disruption	and	DNA	1043	
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homogenization	was	performed	using	a	Pico	Bioruptor	(Diagenode).	Reverse	1044	 crosslinking	was	performed	as	above.	Proteins	were	recovered	from	lysates	using	the	1045	 SP3	method	and	digested	‘on-bead’	with	Lys-C	followed	by	Trypsin.		Peptides	were	then	1046	 recovered	by	SP3,	and	TMT	labelled	according	to	manufacturer’s	instructions.	For	1047	 phosphoenrichment,	TMT	labelled	peptides	were	mixed	and	subjected	to	magnetic	1048	 Ti:IMAC	enrichment	(Resyn	Biosciences)	using	the	manufacturer’s	protocol.	1049	
Immunoblot	analysis	1050	 Lysates	for	SDS-PAGE	analysis	were	prepared	in	lithium	dodecylsulphate	sample	1051	 buffer	(Life	Technologies)	and	25	mM	TCEP.	Samples	were	heated	to	65	°C	for	5	min	1052	 and	then	loaded	onto	a	NuPage	BisTris	4	–	12%	gradient	gel	(Life	Technologies),	in	1053	 either	MOPS,	or	MES	buffer.	Proteins	were	electrophoresed	and	then	wet	transferred	to	1054	 nitrocellulose	membranes	at	35	V	for	1.5	hours.	Membranes	were	then	blocked	in	5%	1055	 BSA	in	immunoblot	wash	buffer	(TBS	+	0.1%	Tween-20)	for	1	hour	at	room	1056	 temperature.	Membranes	were	then	probed	with	primary	antibody	overnight	at	4°C,	1057	 washed	and	then	re-probed	with	LiCor	dye-conjugated	secondary	antibodies	(either	1058	 IRDye-688	or	IRDye-800).	Primary	antibodies	for	cell	cycle	immunoblot	analysis	were	1059	 obtained	from	Cell	Signaling	Technology	(cyclin	B1,	cyclin	A,	cyclin	E,	CDT1).	Bands	1060	 were	visualized	using	the	Odyssey	CLx	scanner	(LiCor	Biosciences).	1061	
Offline	HPLC	and	LC-MS/MS	analysis	1062	 Chloroform-methanol	precipitated	protein	pellets	were	resuspended	in	8	M	urea	1063	 in	digest	buffer	(100	mM	Tris	pH	8.0,	1	mM	CaCl2).	The	protein	solution	was	then	1064	 diluted	to	4	M	urea	with	digest	buffer	and	then	digested	with	Lys-C,	which	was	added	at	1065	 a	1:50	w/w	Lys-C:protein	ratio	from	a	1	mg/ml	stock	in	water	(Wako	Chemicals)	1066	 overnight	at	37°C.	The	lysates	were	then	further	diluted	with	digest	buffer	to	0.8	M	urea	1067	 and	digested	with	trypsin,	which	was	added	at	a	1:50	w/w	trypsin:protein	ratio	from	a	1068	
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0.2	mg/ml	stock	in	50	mM	acetic	acid	(Thermo	Pierce)	for	four	hours	at	37°C.	The	1069	 digests	were	then	desalted	using	SepPak-C18	SPE	cartridges,	dried,	and	resuspended	in	1070	 5%	formic	acid.	Peptide	concentrations	were	determined	using	the	amine-reactive,	1071	 fluorogenic	CBQCA	assay	(Life	Technologies).	1072	 SP3-processed	proteins	were	digested	in	a	similar	manner	to	above.	For	one	1073	 biological	replicate,	the	resulting	peptides	were	TMT-labelled	according	to	1074	 manufacturer’s	instructions.	Peptides	(SILAC	or	TMT)	were	then	mixed,	dried,	and	1075	 resuspended	in	high	pH	reverse	phase	buffer	A	(10	mM	ammonium	formate	in	2%	ACN,	1076	 pH	9.3).	Peptides	were	then	chromatographed	on	a	Dionex	Ultimate	3000	off-line	HPLC	1077	 equipped	with	a	XBridge	Peptide	BEH	C18	4.6	mm	x	250	mm	column	packed	with	3.5	1078	 µm	particles	containing	130	angstrom	pores	(Waters)	and	a	standard	gradient	over	20	1079	 min	from	25%	at	0	min	to	60%	B	at	11	min	(10	mM	ammonium	formate	in	80%	ACN,	1080	 pH	9.3)	at	a	flow	rate	of	1	ml/min.	48	fractions	were	collected	into	24	wells	in	a	1081	 concatenated	format.	1082	 SILAC-labelled	peptides	were	analyzed	using	a	Dionex	RSLCnano	HPLC-coupled	1083	 Q-Exactive	Orbitrap	mass	spectrometer	(Thermo	Fisher	Scientific).	Peptides	were	first	1084	 loaded	onto	a	2	cm	PepMap	trap	column	in	2%	acetonitrile	+	0.1%	formic	acid.	Trapped	1085	 peptides	were	then	separated	on	an	analytical	column	(75	μm	x	50	cm	PepMap-C18	1086	 column)	using	the	following	mobile	phases:	2%	acetonitrile	+	0.1%	formic	acid	(Solvent	1087	 A)	and	80%	acetonitrile	+	0.1%	formic	acid	(Solvent	B).	The	linear	gradient	began	with	1088	 5%	B	to	35%	B	over	220	min	with	a	constant	flow	rate	of	200	nl/min.	The	peptide	1089	 eluent	flowed	into	a	nanoelectrospray	emitter	at	the	front	end	of	a	Q-Exactive	Plus	1090	 (quadrupole	Orbitrap)	mass	spectrometer	(Thermo	Fisher	Scientific).	A	typical	‘Top10’	1091	 acquisition	method	was	used.	Briefly,	the	primary	mass	spectrometry	scan	(MS1)	was	1092	 performed	in	the	Oribtrap	at	70,000	resolution.	Then,	the	top	10	most	abundant	m/z	1093	
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signals	were	chosen	from	the	primary	scan	for	collision-induced	dissociation	in	the	HCD	1094	 cell	and	MS2	analysis	in	the	Orbitrap	at	17,500	resolution.	Precursor	ion	charge	state	1095	 screening	was	enabled	and	all	unassigned	charge	states,	as	well	as	singly	charged	1096	 species,	were	rejected.	1097	 TMT-labelled	peptides	were	analyzed	using	a	Dionex	RSLCnano	HPLC-coupled	1098	 Tribrid	Fusion	mass	spectrometer	(Thermo	Fisher	Scientific).	Peptides	were	first	1099	 loaded	onto	a	2	cm	PepMap	trap	column	(100	µm)	in	2%	acetonitrile	+	0.1%	formic	1100	 acid.	Trapped	peptides	were	then	separated	on	an	analytical	column	(75	μm	x	50	cm	1101	 PepMap-C18	column)	using	the	following	mobile	phases:	2%	acetonitrile	+	0.1%	formic	1102	 acid	(Solvent	A)	and	80%	acetonitrile	+	0.1%	formic	acid	(Solvent	B).	The	linear	1103	 gradient	began	with	5%	B	to	35%	B	over	220	min	with	a	constant	flow	rate	of	200	1104	 nl/min.	The	peptide	eluent	flowed	into	a	nanoelectrospray	emitter	at	the	front	end	of	1105	 either	a	Q-Exactive,	or	Q-Exactive	Plus	(quadrupole	Orbitrap)	mass	spectrometer	1106	 (Thermo	Fisher	Scientific).	A	max	cycle	time	acquisition	method	was	used	(2s).	The	1107	 primary	mass	spectrometry	scan	(MS1)	was	performed	in	the	Oribtrap	at	120,000	1108	 resolution.	Then,	the	top	N	most	abundant	m/z	signals	were	chosen	from	the	primary	1109	 scan	for	CID	(30%)	and	Rapid-mode	MS2	analysis	in	the	linear	ion	trap.		A	synchronous	1110	 precursor	selection	(SPS)	method	was	employed.	MS2	product	ions	were	selected	using	1111	 4	notches	with	a	maximum	injection	time	of	300	ms,	fragmented	by	HCD	(55%),	and	1112	 TMT	tags	mass	analysed	in	the	Orbitrap	at	60,000	resolution.	Precursor	ion	charge	state	1113	 screening	was	enabled	and	all	unassigned	charge	states,	as	well	as	singly	charged	1114	 species,	were	rejected.	1115	
MS	data	analysis	1116	 The	SILAC	and	TMT	RAW	data	files	produced	by	the	mass	spectrometer	were	1117	 analysed	using	the	quantitative	proteomics	software	MaxQuant,	versions	1.5.1.2	and	1118	
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1.5.3.30	(Cox	&	Mann	2008).		This	version	of	MaxQuant	includes	an	integrated	search	1119	 engine,	Andromeda	(Scheltema	et	al.	2011).	The	database	supplied	to	the	search	engine	1120	 for	peptide	identifications	was	a	UniProt	human	protein	database	(‘Human	Reference	1121	 Proteome’	retrieved	on	April	16,	2016)	combined	with	a	commonly	observed	1122	 contaminants	list.	The	initial	mass	tolerance	was	set	to	7	p.p.m.	and	MS/MS	mass	1123	 tolerance	was	20	ppm.	The	digestion	enzyme	was	set	to	trypsin/P	with	up	to	2	missed	1124	 cleavages.	Deamidation,	oxidation	of	methionine	and	Gln->pyro-Glu	were	searched	as	1125	 variable	modifications.	Identification	was	set	to	a	false	discovery	rate	of	1%.	To	achieve	1126	 reliable	identifications,	all	proteins	were	accepted	based	on	the	criteria	that	the	number	1127	 of	forward	hits	in	the	database	was	at	least	100-fold	higher	than	the	number	of	reverse	1128	 database	hits,	thus	resulting	in	a	false	discovery	rate	of	less	than	1%.	Protein	isoforms	1129	 and	proteins	that	cannot	be	distinguished	based	on	the	peptides	identified	are	grouped	1130	 by	MaxQuant	and	displayed	on	a	single	line	with	multiple	UniProt	identifiers.	The	label	1131	 free	quantitation	(LFQ)	algorithm	in	MaxQuant	was	used	for	protein	quantitation.	The	1132	 algorithm	has	been	previously	described	(Cox	2014).	MaxQuant	output	was	analysed	in	1133	 RStudio	v1.0.136	with	R	v3.3.0.	Protein	quantitation	was	performed	on	unmodified	1134	 peptides	and	peptides	that	have	modifications	that	are	known	to	occur	during	sample	1135	 processing	(pyro-Glu,	deamidation).	All	resulting	MS	data	were	integrated	and	managed	1136	 using	PepTracker	Data	Manager,	a	laboratory	information	management	system	(LIMS)	1137	 that	is	part	of	the	PepTracker	software	platform	(http://www.PepTracker.com).	1138	 For	the	interphase	proteomic	dataset,	proteins	were	filtered	to	eliminate	1139	 potential	contaminants	and	reverse	hits.	For	each	of	the	four	biological	replicates,	1140	 normalised	SILAC	ratios	were	normalized	to	the	ratio	measured	in	G1.	A	median	ratio	1141	 was	calculated	between	replicates.	The	maximum	fold	change	across	a	single	1142	 experiment	(i.e.	between	G1,	S,	G2,	and	M	phase)	was	calculated.	The	distribution	of	1143	
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maximum	fold	changes	was	then	used	to	calculate	fold	change	cutoffs	were	using	Z-1144	 scoring,	i.e.	the	median	±	1.96	*	the	sample	standard	deviation.	P-values	were	calculated	1145	 using	a	one-way	ANOVA	with	the	four	biological	replicates,	excluding	proteins	with	1146	 missing	values.	The	p-value	cutoff	was	arbitrarily	set	to	0.05.	Proteins	that	met	the	fold	1147	 change	and	p-value	cutoffs	were	deemed	significantly	different	in	abundance	between	1148	 the	cell	cycle	fractions.	1149	 For	the	interphase	phosphorylation	dataset,	raw	data	were	analysed	using	1150	 MaxQuant		1151	 For	the	mitotic	subphases	proteomic	dataset,	SILAC	ratios	were	normalized	to	1152	 the	prophase	fraction,	in	a	similar	fashion	to	the	interphase	dataset	(which	was	1153	 normalized	to	G1).	The	TMT	reporter	channels,	126,	127N,	128C,	129N,	130C,	and	131,	1154	 relate	to	G2,	M,	Pro,	PM2,	PM1,	and	Ana	fractions,	respectively.	TMT	reporter	intensities	1155	 were	corrected	for	isotope	contamination	(Lot	QL226165A)	and	normalized	by	dividing	1156	 each	TMT	reporter	by	the	sum	of	TMT	reporter	intensities.		TMT	reporter	ratios	were	1157	 then	calculated	by	dividing	by	the	prophase	(Pro)	TMT	reporter	intensity.	Thus	TMT	1158	 and	SILAC	experiments	are	both	normalized	to	the	same	fraction.	The	TMT	and	SILAC	1159	 datasets	were	merged	using	the	Leading	Razor	Protein	UniProt	identifier.	Correlation	1160	 coefficients	between	the	three	biological	replicates	were	calculated	for	the	patterns	1161	 across	Pro,	PM1,	PM2,	and	Ana	fractions	in	a	pairwise	fashion	(“cor	1vs2”,	“cor	1vs3”,	1162	 and	“cor	2vs3”	in	Supplementary	File	4).	A	fold	change	cutoff	based	on	maximum	fold	1163	 change	was	calculated	using	Z-scoring	as	above.	Proteins	that	a)	have	at	least	one	pair	of	1164	 biological	replicates	with	a	correlation	coefficient	greater	than	0,	and	b)	meet	the	fold	1165	 change	cutoff	were	deemed	to	be	significantly	changed.	1166	 Protein	profiles	were	clustered	using	k-means,	where	k	=	12.	The	appropriate	k	1167	 was	determined	by	identifying	the	inflection	point	in	a	plot	of	within	groups	sum	of	1168	
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squares	vs	the	number	of	clusters.	Clusters	showing	increased	abundance	were	1169	 removed	and	remaining	clusters	were	agglomerated	into	three	groups	based	on	1170	 ‘earliest’	fraction	showing	decreased	abundance.		1171	1172	
	 50	
Acknowledgements			This	work	was	supported	by	grants	to	AIL	from	the	Wellcome	Trust	(105024/Z/14/Z,	108058/Z/15/Z)	and	the	EU	EpiGeneSys	network	(Grant#:	HEALTH-F4-2010-257082).	We	thank	the	UK	Research	Partnership	Investment	Fund	and	the	Scottish	Funding	Council	(Project	H13047)	for	proteomics	instrumentation	funding	and	the	Wellcome	Trust	(097418/Z/11/Z)	for	supporting	the	Flow	Cytometry	and	Cell	Sorting	Facility	at	the	University	of	Dundee.	We	thank	Barbara	Mann	and	Cassandra	Pelletier	for	assisting	with	initial	experiments	on	the	TPX2	mutants.	We	thank	our	colleagues	in	the	Lamond	group	for	advice	and	discussion.	We	thank	Calum	Thompson	and	Alan	Prescott	(Dundee	Light	Microscopy	Facility),	the	Swedlow	laboratory,	and	Raffaella	Pippa	(Lamond	lab)	for	technical	advice	and	assistance.		
Figure	Captions		
Figure	1.	An	optimised	workflow	for	intracellular	immunostaining,	FACS,	and	MS-
based	proteomics.	A)	An	abbreviated	schematic	of	the	workflow	for	the	Proteomics	of	Intracellluar	IMMunostained	Subpopulations	(PRIMMUS)	approach,	highlighting	specific	steps	for	optimization	(fixation,	permeabilisation).	Lysates	prepared	from	cells	crosslinked	with	the	indicated	concentrations	of	formaldehyde	(%v/v)	in	PBS	(B)	and	then	de-crosslinked	with	heating	(C)	were	electrophoresed	by	SDS-PAGE	and	stained	for	protein	using	Sypro	Ruby.	D)	.	SILAC	labelled	cells	were	either	processed	by	fixation	and	permeabilisation,	comparing	0.5%	Triton	X-100	(i)	versus	90%	methanol	(ii),	or	with	lysis	only	(iii).	Cells	were	then	mixed	pairwise	1:1	and	analysed	by	‘single	shot’	proteome	workflows.	The	resulting	SILAC	ratios	(e.g.,	H/L)	are	plotted	as	scatter	plots	for	the	pairwise	comparisons,	namely	Triton	X-100	vs.	lysis	only,	methanol	vs	lysis	only,	and	methanol	versus	methanol	(technical	replicate).				
Figure	2.	Purification	of	interphase	and	mitotic	cells	for	PRIMMUS.	Workflow	for	PRIMMUS	of	human	leukemia	cells	into	four	cell	cycle	phase	fractions	(G1,	S,	G2,	and	M).	Stained	cells	were	sorted	by	FACS	into	four	populations	(G1,	S,	G2,	and	M)	based	on	the	gates	shown	on	the	psuedocolour	plot	in	(B).	The	mitotic	index	of	the	M	phase	fraction	was	independently	visualised	by	immunofluorescence	microscopy	and	co-staining	for	microtubules	(C)	and	quantitated	(D).	Fractions	were	then	mixed	by	cell	number	1:1	with	an	asynchronous	SILAC-labelled	standard	and	processed	for	‘single	shot’	LC-MS/MS	based	proteomics.	The	resulting	measured	SILAC	ratios	compare	protein	abundances	in	the	sorted	fraction	versus	the	asynchronous	standard	(E).	The	analysis	was	performed	with	replicates	(n	=	4).	Comparison	of	peptide	ID	rates	across	the	sorted	fractions	(F).		
Figure	3.	Proteomic	measurement	of	protein	accumulation	across	the	cell	division	
cycle.	(A)	A	‘neeps’	plot	showing	the	distribution	of	log2	SILAC	ratios	measured	in	each	of	the	G1,	S,	G2,	and	M	subpopulations	in	one	representative	replicate.	The	width	of	each	‘neep’	is	proportional	to	the	density,	i.e.	the	number	of	proteins.	Quartiles	are	marked	by	black	lines,	and	interquartile	ranges	are	indicated	by	shading.	B,	inset)	A	schematic	showing	the	cell	division	cycle	and	the	average	position	during	the	cell	division	cycle	for	each	phase	collected,	where	a	newly	divided	cell	is	defined	as	t	=	0,	and	cell	division	
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(cytokinesis)	is	defined	as	t	=	1.	B,	graph)	Regression	analysis	was	performed	to	produce	a	best-fit	line	in	the	form	of	an	exponential	growth	model	(i.e.,	y	=	emx).	(C)	Ratios	of	proteins	belonging	to	each	of	the	indicated	GO	terms	were	averaged	(mean)	and	visualized	using	a	heatmap.	(D)	A	plot	of	ratios	of	individual	proteins	associated	with	mitosis,	chromatin,	and	the	stress	response	versus	cell	cycle	stage.		E)	A	comparison	of	the	ratio	of	G2&M	vs.	asynchronous	measured	in	the	elutriation	vs.	PRIMMUS	datasets.		
Figure	4.	Reproducible	analysis	of	phosphorylation	changes	across	the	cell	
division	cycle.	A)	Workflow	for	phosphorylation	analysis	of	FACS	separated	cell	cycle	states.	B)	Distribution	of	phosphorylated	residues	detected.	C)	Percentage	of	phosphorylation	site	sequences	matching	reported	consensus	substrate	phosphorylation	motifs	(www.elm.eu.org)(Dinkel	et	al.	2016).	D)	Gene	ontology	enrichment	analysis	of	the	detected	phosphoproteins	(ReviGO)(Supek	et	al.	2011).	E)	Phosphorylation	profiles	across	the	four	FACS	separated	fractions	for	replicate	1	and	2.	F)	A	histogram	of	correlation	coefficients	calculated	for	individual	phosphorylation	sites	between	the	two	replicates.	G)	A	comparison	of	measured	maximum	fold	change	between	replicates.		
Figure	5.	Increased	global	mitotic	phosphorylation	dominated	by	a	subset	of	
highly	phosphorylated	proteins.	A)	K-means	clustering	of	the	phosphorylation	profiles.	B)	Distribution	of	mitosis-peaking	phosphorylation	sites,	either	in	the	entire	dataset	(left),	or	significantly	changing	phosphorylation	sites	(right).	C)	A	comparison	of	phosphorylation	site	ratios	measured	in	this	dataset	and	a	previous	analysis	of	mitotic	phosphorylation	in	human	cells.		
Figure	6.	Identification	of	‘early	risers’,	a	subset	of	mitotic	phosphorylations	that	
begin	increasing	in	G2	phase.	A)	Gene	ontology	enrichment	analysis	of	early	rising	phosphorylation	sites.	B)	A	STRING	network	analysis	of	early	rising	phosphoproteins.	Nodes	with	one	or	more	connections	are	shown.	C)	Enriched	sequence	motifs	among	early	rising	phosphorylation	sites	(Motif-X).	D)	Comparing	the	M-phase	ratio	between	‘early	rising’	and	‘late	rising’	phosphorylation	sites.	Error	bars	show	s.e.m.		
Figure	7.	Mitotic	defects	in	cells	expressing	phosphodefective	and	
phosphomimetic	mutants	of	TPX2-738.		A)		Bar	graph	showing	percentages	of	mitotic	spindles	with	the	indicated	phenotypes.		Collapsed	spindles	have	large	asters	and	short	intervening	spindle;	spindles	classified	as	other	include	monopolar,	multipolar,	bent	and	misshapen	spindles.		B)	Representative	examples	of	spindle	phenotypes.		Bar	=	5	microns.		C)	Box	and	whisker	plot	of	mitotic	duration,	defined	as	nuclear	envelope	breakdown	to	anaphase	onset.			
Figure	8.	Proteome-wide	analysis	of	protein	abundance	changes	between	mitotic	
subphases.	A)	Flow	cytometry	analysis	of	NB4	cells	immunostained	for	H3S28ph	and	CycA.	Gates	show	populations	collected	by	FACS.	A,	right)	Representative	light	microscopy	images	of	cell	fractions.	B)	The	frequency	of	each	intra-mitotic	stage	was	counted	and	quantified	with	100	cells	or	more.	C)	Wider	field	of	view	of	population	4,	i.e.,	the	anaphase-enriched	population.	D)	Workflow	for	MS-based	proteomic	analysis	involving	SILAC	and	TMT	based	labelling	and	3	biological	replicates,	resulting	in	8,700	proteins	identified	in	total.	E)	Pie	chart	indicating	the	percentage	of	significantly	
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changing	proteins	(see	text	for	criteria	for	significance).	F)	K-means	clustering	of	profiles	were	qualitatively	agglomerated	into	three	groups	based	on	subpopulation	where	‘trough’	in	abundance	occurs.	G)	A	pie	chart	showing	the	number	and	proportion	of	proteins	in	each	protein	group	indicated	in	(F).		
Figure	9.	Ribonucleotide	reductase	M2	(RRM2)	is	degraded	during	prometaphase	
in	a	proteasome-dependent,	MLN-4924	sensitive	manner.	A)	Line	graphs	showing	mean	abundance	profiles	for	Cyclin	A2	(CycA),	Cyclin	B1,	Cyclin	B2,	and	GAPDH.	Grey	ribbons	indicate	1	standard	deviation	from	the	mean.	B)	Mean	abundance	profile	for	RRM2.	C)	Flow	cytometry	analysis	RRM2	levels	vs.	DNA	content.	D)	Flow	cytometry-based	comparison	of	beta-tubulin	(negative	control,	left)	and	RRM2	(right)	levels	in	CycA+	(red)	vs.	CycA-	(blue)	prometaphase	cells.	E)	Violin	plots	showing	CycA,	histone	H3,	and	RRM2	levels	in	cells	treated	with	either	DMSO	or	microtubule	drugs	that	activate	the	spindle	assembly	checkpoint	(nocodazole,	monastrol,	taxol).	F)	Violin	plots	showing	levels	of	RRM2	in	cells	treated	with	either	vehicle	control	(DMSO),	MG132,	apcin+proTAME,	or	MLN4924.			
Figure	10. The	PRIMMUS	cell	cycle	data	is	accessible	through	the	Encyclopaedia	of	
Proteome	Dynamics	(EPD).	User	interface	features	include:	A)	specifying	type	of	search,	including	search	for	individual	proteins,	GO	term,	and	CORUM	complex	membership,	B)	an	input	box	for	protein	and	other	(e.g.	GO	term)	identifiers,	C)	a	ribbon	graph	showing	plots	for	input	protein	identifiers	(here	for	illustration	are	shown	RRM2	and	CCNB1)	with	lines	indicating	mean	profile	and	ribbons	indicating	s.e.m.,	D)	an	interactive	legend	to	show	more	information	on	individual	proteins,	and	E)	options	to	output	visualisation	as	an	SVG	file	or	underlying	data	in	CSV	format.	F)	Data	from	other	cell	cycle	proteomic	datasets	from	the	Lamond	laboratory	can	be	easily	visualized	for	the	same	proteins	using	the	navigation	bubble	map.	G)	An	example	plot	correlating	protein	abundance	and	phosphorylation	changes.	Several	proteins	containing	‘early	rising’	phosphorylation	sites	are	highlighted:	CENPF,	TMPO,	and	RIF1.		
Figure	1	Figure	Supplement	1.	Immunoblot	analysis	of	the	effect	of	FA	on	the	
electrophoretic	migration	of	individual	proteins.	Immunoblot	analysis	of	crosslinked	lysates	for	alpha	tubulin	(A)	and	histone	H3	(B).	Immunoblot	analysis	of	crosslinked	&	reverse	crosslinked	lysates	for	alpha	tubulin	(C)	and	histone	H3	(D).	Arrowheads	indicate	high	MW	bands	remaining	after	reverse	crosslinking	step	that	migrate	at	a	higher	MW	than	the	expected	monomer	mass	(arrows).		
	
Figure	1	Figure	Supplement	2.	The	effects	of	formaldehyde	(FA)	concentration	on	
protein	crosslinking	and	DNA	staining.	A)	DNA	content	histograms	from	flow	cytometry	of	cells	fixed	with	the	indicated	concentrations	of	FA	and	using	either	propidium	iodide	(PI,	left),	or	4',6-diamidino-2-phenylindole	(DAPI,	right),	as	the	DNA-binding	dye.			
Figure	1	Figure	Supplement	3.	Formaldehyde-induced	modifications	are	
relatively	infrequent.	The	MaxQuant	analysis	was	repeated	in	the	‘data-dependent	mode’,	which	takes	peptides	identified	using	a	normal	database	search,	and	opens	the	modification	space	to	potentially	detect	unspecified	mass	modifications.	Shown	are	the	number	of	peptides	modified	with	a	mass	that	would	be	consistent	with	formaldehyde-induced	modifications	(i.e.	methylene	and	methoyl).	For	comparison,	the	number	of	
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peptides	modified	with	a	mass	consistent	with	carbamylation,	a	urea-induced	modification,	is	shown.		
Figure	4	Figure	Supplement	1.	Comparison	of	phosphopeptide	identifications	between	control	and	fixed,	permeabilised	samples	shows	no	significant	difference	in	identification	rate.	Three	biological	replicates	comparing	control	and	PRIMMUS	samples	were	analysed.	The	y-axis	is	the	relative	number	of	phosphopeptides	normalised	to	control.		
Figure	5	Figure	Supplement	1.	K-means	clustering	of	the	phosphorylation	profiles	
normalized	to	total	protein	abundance.		
Figure	9	Figure	Supplement	1.	Validation	of	the	anti-RRM2	antibody	used	in	this	study.	Flow	cytometry	analysis	of	cells	treated	either	with	non-targeting	siRNA	(siJumble),	or	siRNA	against	RRM2	and	stained	either	with	secondary	antibody	only	(A),	or	anti-RRM2	antibody	(B).	C)	Immunoblot	analysis	of	siJumble	vs.	siRRM2	cell	lysates.	D)	Overexpression	of	GFP-Fibrillarin	(top)	and	RRM2-GFP	(bottom).	GFP	and	anti-RRM2	staining	shows	high	correlation.		
Figure	9	Figure	Supplement	2.	RRM2	is	cell	cycle	regulated	in	U2OS	cells,	showing	
peak	abundance	in	G2	phase.	A)	A	representative	image	of	FUCCI	U2OS	cells	immunostained	for	RRM2.	B)	A	psuedocolour	scatter	plot	with	x-	and	y-	axes	representing	the	two	proteins	used	in	the	FUCCI	cell	cycle	reporter	system	(Red:	Cdt1,	Green:	Geminin)	with	colour	indicating	anti-RRM2	signal.	C)	Bar	chart	summarising	(B).		
Figure	9	Figure	Supplement	3.		RRM2	abundance	decreases	during	early	mitosis	
in	U2OS	cells.	anti-Cyclin	B1	and	anti-RRM2	signals	were	measured	in	U2OS	cells	by	immunofluorescence	microscopy.	Representative	images	of	cyclin	B	(A,	left)	and	RRM2	(A,	right)	staining.	C)	Quantitation	of	immunofluorescence	with	cells	ranked	ordered	based	on	Cyclin	B1	signal.	The	arrow	indicates	nuclear	concentration	of	Cyclin	B1	signal,	which	marks	mitotic	entry.			Akopyan,	K.	et	al.,	2014.	Assessing	Kinetics	from	Fixed	Cells	Reveals	Activation	of	the	Mitotic	Entry	Network	at	the	S/G2	Transition.	Molecular	Cell,	53(5),	pp.843–853.	Amanchy,	R.	et	al.,	2007.	A	curated	compendium	of	phosphorylation	motifs.	Nature	
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Supplementary	Files	
		
Supplementary	File	1.	The	effect	of	fixation	and	permeabilisation	protocols	on	
MS-based	protein	quantitation.	A	tab-delimited	text	file	containing	a	list	of	all	the	protein	groups	identified	with	≥2	peptides	per	protein	group	and	their	associated	SILAC	ratios	comparing	the	different	fixation	and	permeabilisation	protocols.			
Supplementary	File	2.	Analysis	of	protein	accumulation	across	interphase	and	
mitosis.	The	table	consists	of	an	excel	file	containing	two	worksheets.	The	first	worksheet	lists	the	protein	groups	identified	with	≥2	peptides	per	protein	group	and	their	associated	SILAC	ratios	in	four	biological	replicates.	For	each	biological	replicate,	the	ratios	were	normalised	to	the	ratio	measured	in	G1.	An	offset	was	then	added	to	the	G1	ratio	to	account	for	the	difference	in	time	between	cell	division	and	an	average	G1	cell	(calculated	from	Figure	5B).	The	second	worksheet	also	lists	the	same	protein	groups,	but	with	the	unnormalised	ratios.	These	are	the	ratios	that	were	used	to	produce	the	‘neeps’	plot	in	Figure	5A.		
Supplementary	File	3.	Analysis	of	protein	phosphorylation	across	interphase	and	
mitosis.	The	table	consists	of	a	tab-delimited	file	containing	the	phosphorylation	sites	measured,	quality	measures	(PEP,	Score),	and	TMT	ratios	calculated	relative	to	the	G1	fraction	from	the	two	biological	replicates.	B	–	biological	replicate,	fc	–	fold	change,	repcor	–	Pearson’s	correlation	score	between	the	ratio	patterns	of	the	two	biological	replicates		
Supplementary	File	4.	Analysis	of	protein	abundances	during	mitotic	subphases.	The	table	consists	of	a	tab-delimited	file	containing	the	proteins	identified,	quality	measures	(Q-value,	Score,	number	of	peptides),	TMT	ratios	calculated	relative	to	the	prophase	fraction,	and	SILAC	ratios	calculated	relative	to	the	prophase	fraction	in	biological	duplicate.	cor	–	Pearson’s	correlation	score	between	the	ratio	patterns	of	the	three	biological	replicates	(only	mitotic	subphases	are	compared).	numcor	–	number	of	times	the	Pearson’s	correlation	score	is	greater	than	0.			
